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Among 65 species belonging to the genus Cornus only two, Cornus mas L. and
Cornus officinalis Sieb. et Zucc. (Cornaceae), have been traditionally used since ancient
times. Cornus mas (cornelian cherry) is native to southern Europe and southwest
Asia, whereas C. officinalis (Asiatic dogwood, cornel dogwood) is a deciduous tree
distributed in eastern Asia, mainly in China, as well as Korea and Japan. Based on the
different geographic distribution of the closely related species but clearly distinct taxa,
the ethnopharmacological use of C. mas and C. officinalis seems to be independently
originated. Many reports on the quality of C. mas fruits were performed due to their value
as edible fruits, and few reports compared their physicochemical properties with other
edible fruits. However, the detailed phytochemical profiles of C. mas and C. officinalis, in
particular fruits, have never been compared. The aim of this review was highlighting the
similarities and differences of phytochemicals found in fruits of C. mas and C. officinalis
in relation to their biological effects as well as compare the therapeutic use of fruits from
both traditional species. The fruits of C. mas and C. officinalis are characterized by the
presence of secondary metabolites, in particular iridoids, anthocyanins, phenolic acids
and flavonoids. However, much more not widely known iridoids, such as morroniside, as
well as tannins were detected particularly in fruits of C. officinalis. The referred studies
of biological activity of both species indicate their antidiabetic and hepatoprotective
properties. Based on the available reports antihyperlipidemic and anticoagulant activity
seems to be unique for extracts of C. mas fruits, whereas antiosteoporotic and
immunomodulatory activities were assigned to preparations of C. officinalis fruits. In
conclusion, the comparison of phytochemical composition of fruits from both species
revealed a wide range of similarities as well as some constituents unique for cornelian
cherry or Asiatic dogwood. Thus, these phytochemicals are considered the important
factor determining the biological activity and justifying the use of C. mas and C. officinalis
in the traditional European and Asiatic medicine.
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INTRODUCTION
Recently published ethnopharmacological studies regarding the
genus Cornus (Cornaceae) have shown that among 65 species
only two of them have a long tradition in a medicinal use. Cornus
mas L. native to southern Europe and southwest Asia, known as
cornelian cherry, is used since ancient times (Dragendorff, 1898).
The fruits of this plant were used for a broad variety of diseases
and complaints in all areas of its geographical distribution.
The preparations from C. mas (European cornel, cornelian
cherry) were considered as astringent, tonic and antipyretic
remedies (Fournier, 1948). Cornus officinalis Sieb. et Zucc., also
named Asiatic dogwood (cornel dogwood, Japanese cornel), is
a deciduous tree distributed in eastern Asia, mainly in China,
as well as Korea and Japan (Ma et al., 2014). It was used as
a traditional Chinese medicine for more than 2,000 years to
promote a healthy liver and kidney, and is a common ingredient
of many TCM prescriptions (Liu X. et al., 2011).
The dogwood genus Cornus L. is a member of Cornales in
the Asterids clade (The Angiosperm Phylogeny Group; APG
IV, 2016). The dogwood genus is morphologically heterogenous,
variable in inflorescences, fruits and chromosomes (Eyde, 1988;
Xiang et al., 2005; Ma et al., 2017). Four major lineages of the
dogwood genus Cornus L., such as the blue- or white-fruited
group, the cornelian cherry group, the big-bracted group and
the dwarf dogwood group, have been drawn (Xiang et al., 2006,
2008). However, the systematical classification of flowering plants
from Cornales clade and relationships within this taxon seems
to be problematic for many years (Xiang et al., 1996, 1998,
2002, 2006; Fan and Xiang, 2001; APG IV, 2016). Despite these
controversies, phylogenetic analyses of this clade based on four
DNA regions, such as rbcL and matK from chloroplast DNA
genome as well as 26S rDNA and ITS (internal transcribed
spacer) 1–5. 8S rDNA from the nuclear genome, classified both
C. mas and C. officinalis in the group of cornelian cherries
(Xiang et al., 1998, 2002, 2006; Fan and Xiang, 2001). In
addition, the subgenera Afrocarnia (Harms) Wangerin, Cornus
L. and Sinocornus Q.Y. Xiang were included into the group of
cornelian cherries. Cornus mas and C. officinalis were classified
in the subgenus Cornus L. (Fan and Xiang, 2001; Xiang et al.,
2006). Both of them are temperate deciduous small shrubs or
trees blooming before leaf development. The morphological
characters, such as umbellate cymes terminal subtended by four
not showy scale-like bracts, red or purple black fruits and the wall
of fruit stone riddled with cavities, supported the membership of
these species in the monophyletic group of cornelian cherries. All
these data strongly supported the sister phylogenetic relationship
of C. mas and C. officinalis (Xiang et al., 2005). The genus Cornus
is widely distributed in the northern hemisphere. Fossil fruit
stones similar to the contemporary fruit stones of C. mas are
likely to derive from the late Miocene of Poland, as well as from
Pliocene and Pleistocene of France, Germany and Netherlands.
Evidence from analyses of fossils, phylogeny and biogeographic
distribution support an origin and early diversification of Cornus
likely in Europe. It is suggested that the ancestor of the living
cornelian cherries spread from Europe to eastern Asia around
the mid-Oligocene and the mid-Miocene. Cornus mas is a
single representative species of cornelian cherry in Europe. On
the other hand, C. officinalis in eastern Asia represents the
Miocene migrant from Europe (Xiang et al., 2005). Based on
the different geographic distribution of the closely related species
but clearly distinct taxa, the ethnopharmacological use of C. mas
and C. officinalis seems to be independently originated. In the
traditional medicine of Europe and Middle East only fruits of
C. mas were used and in the traditional medicine of China
reports describe only preparations of fruits from C. officinalis for
medicinal application.
Plant materials belonging to the genus Cornus are
characterized by the presence of secondary metabolites, in
particular iridoids, anthocyanins, tannins and flavonoids.
Although many reports on the quality of fruits of C. mas
were performed due to the fact of their value as edible
fruits, as well as few studies compared their properties with
other edible fruits used for a production of wines, liquors
or jams (Tarko et al., 2014; Cosmulescu et al., 2017), the
detailed phytochemical profiles of C. mas and C. officinalis,
in particular fruits, have never been compared. The chemical
composition of plant materials obtained from C. mas and
C. officinalis can be significantly different depending on
the geographic location, climatic factors, season, as well
as cultivation practice. For this reason, the phytochemical
composition is considered an important factor determining
the biological activity and justifying the traditional use of these
species.
All these facts taking together make interesting to compare
the therapeutic use of both traditional species based on their
chemical composition. This review particularly highlights the
similarities and differences in phytochemicals found in fruits of
C.mas andC. officinalis in relation to their biological effects based
on reports available in this field.
SIMILARITIES AND DIFFERENCES IN THE
CHEMICAL COMPOSITION OF FRUITS
FROM C. MAS AND C. OFFICINALIS
General
The main secondary metabolites found in dogwoods seem to
be iridoid and non-flavonoid glucosides. Even though the blue-
fruited dogwoods contain non-flavonoid glucoside salidroside
derived from shikimic acid, iridoid glucosides were found to be
unique in all red-fruited dogwoods, and they are derived from
mevalonic acid (Bate-Smith et al., 1975; Jensen et al., 1975). The
dogwoods iridoids were classified into three groups, including
cornin and its precursor dihydrocornin, monotropein and its
precursor geniposide as well as secoiridoids, secologanin and
morroniside (Bate-Smith et al., 1975). Thus, the presence of
iridoids (Figures 1, 2) in red-fruited dogwoods is considered a
symplesiomorphy (Xiang et al., 1996), and confirms the close
taxonomical relationship of C. mas and C. officinalis. The
representative compounds of this group, such as loganin, loganic
acid, cornin, sweroside, and cornuside, have been found in both
species.
Furthermore, the polyphenolic compounds are represented by
anthocyanins, flavonoids and phenolic acids in fruits of C. mas
and C. officinalis. Pelargonidin 3-O-galactoside followed by
Frontiers in Pharmacology | www.frontiersin.org 2 August 2018 | Volume 9 | Article 894
Czerwin´ska and Melzig Comparison Cornus mas vs. C. officinalis
FIGURE 1 | The chemical structures of iridoids identified in fruits of C. mas and/or C. officinalis.
cyanidin 3-O-galactoside and delphinidin 3-O-galactoside were
the most abundant anthocyanins in fruits of both species. Among
flavonoids, quercetin, and kaempferol glycosides were detected in
both species. Taking into consideration that flavonoids are widely
distributed in plants, their occurrence was considered the similar
characteristic for both species. Nevertheless, some discrepancy
in the flavonoid composition occurs. Even more flavonoids have
been referred by Huang et al. (2018) but full availability of
the studies concerning their identification or isolation is rather
limited.
Frontiers in Pharmacology | www.frontiersin.org 3 August 2018 | Volume 9 | Article 894
Czerwin´ska and Melzig Comparison Cornus mas vs. C. officinalis
FIGURE 2 | The chemical structures of iridoids identified in fruits of C. officinalis.
Last but not least, the similar constituents of C. mas
and C. officinalis are considered triterpenoids, in particular
represented by ursolic acid detected in both species, and
carbohydrates. It is worth to note that neither in fruits of
C. mas nor in fruits of C. officinalis phenylpropanoid esters
have been reported to date, even though they usually co-exist
with iridoids as it is observed in some plants from Oleaceae,
Scrophulariaceae, Verbenaceae, Plantaginaceae, and Lamiaceae.
This might be justified by the less significant role of shikimate
pathway in biosynthesis of compounds in red-fruited dogwoods.
Table 1 summarizes the key phytochemicals of fruits from
C. mas and C. officinalis that can be found in the literature.
The names of compounds have been provided as they were
described in the referred literature. Due to the fact that HPLC-
MS is currently one of the most popular method for elucidation
of chemical composition of plant preparations, the molecular
weights of phytochemicals were also listed (Table 1) to help
reader with comparing experimental data in order to preliminary
identification detected constituents.
Similarities of Chemical Composition
Iridoids
It is believed that particularly loganin (1) plays a crucial role in
the formation sequences of highly oxidized glucosides of iridoids
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C. mas C. officinalis References
IRIDOIDS
1 Loganin 390 X X Du et al., 2008; Yokozawa et al., 2010; Cao et al., 2011,
2012; Lin et al., 2011; Lee A. Y. et al., 2012; Lee N. H. et al.,
2012; Xie et al., 2012; Cai et al., 2013; Deng et al., 2013; Ma
et al., 2014; Perova et al., 2014; He et al., 2016; Jiang et al.,
2016; Ye et al., 2017
2 8-Epiloganin 390 X Ye et al., 2017
3 Loganic acid 376 X X Yokozawa et al., 2010; Cao et al., 2011, 2012; West et al.,
2012b; Deng et al., 2013; Ma et al., 2014; Sozanski et al.,
2014, 2016; Kucharska et al., 2015; Antolak et al., 2017; Ji
et al., 2017
4 Cornin (verbenalin) 388 X X Cao et al., 2011; Liu Z. et al., 2011; Cai et al., 2013; Perova
et al., 2014; Jiang et al., 2016
5 Sweroside 358 X X Du et al., 2008; Cao et al., 2011, 2012; Liu Z. et al., 2011;
Cai et al., 2013; Deng et al., 2013; Perova et al., 2014; Jiang
et al., 2016; Ye et al., 2017
6 Cornuside 542 X X Hatano et al., 1990; Du et al., 2008; Lin et al., 2011; Liu Z.
et al., 2011; Lee A. Y. et al., 2012; Deng et al., 2013; Ma
et al., 2014; Perova et al., 2014; Sozanski et al., 2014;
Kucharska et al., 2015; Jiang et al., 2016; Antolak et al., 2017
7 Catalposide 482 X Sochor et al., 2014
8 Morroniside 406 X Du et al., 2008; Yokozawa et al., 2010; Cao et al., 2011,
2012; Lin et al., 2011; Lee A. Y. et al., 2012; Lee N. H. et al.,
2012; Cai et al., 2013; He et al., 2016; Jiang et al., 2016; Ji
et al., 2017
9 7-α-O-Methylmorroniside 420 X Ma et al., 2014; Jiang et al., 2016; Ye et al., 2017
10 7-β-O-Methylmorroniside 420 X Xie et al., 2012; Ma et al., 2014; Jiang et al., 2016; Ye et al.,
2017
11 7-α-O-Ethylmorroniside 434 X Cao et al., 2012; Ma et al., 2014; Jiang et al., 2016; Ye et al.,
2017
12 7-β-O-Ethylmorroniside 434 X Cao et al., 2012; Ma et al., 2014; Jiang et al., 2016; Ye et al.,
2017
13 7-O-Methylmorroniside 420 X Liu Z. et al., 2011; Cai et al., 2013; Ji et al., 2017
14 7-O-Ethylmorroniside 434 X Cao et al., 2011; Ji et al., 2017
15 7-β-O-Dimethyl butanedioate
morroniside
550 X Park et al., 2016
16 (7R)-n butyl morroniside 462 X Lin et al., 2011
17 7-α-Morroniside 406 X Xie et al., 2012; Ma et al., 2014; Ye et al., 2017
18 7-β-Morroniside 406 X Xie et al., 2012; Ma et al., 2014; Ye et al., 2017
19 Logmalicid A 506 X Ma et al., 2014
20 Logmalicid B 506 X Ma et al., 2014
21 Cornusfuroside A 542 X He et al., 2017
22 Cornusfuroside B 542 X He et al., 2017
23 Cornusfuroside C 542 X He et al., 2017
24 Cornusfuroside D 622 X He et al., 2017
25 Swertiamarin 374 X Cao et al., 2011; Liu Z. et al., 2011
26 Secoxyloganin 404 X Ma et al., 2014
27 Secologanin (loniceroside) 388 X Jensen et al., 1973
28 Eriobioside 568 X Liu Z. et al., 2011
29 7-Dehymorroniside 404 X Cao et al., 2012
30 7-O-methyloganic acid 390 X Cao et al., 2012
31 Cornuside A 809 X Ye et al., 2017
32 Cornuside B 809 X Ye et al., 2017
(Continued)
Frontiers in Pharmacology | www.frontiersin.org 5 August 2018 | Volume 9 | Article 894
Czerwin´ska and Melzig Comparison Cornus mas vs. C. officinalis





C. mas C. officinalis References
33 Cornuside C 809 X Ye et al., 2017
34 Cornuside D 809 X Ye et al., 2017
35 Cornuside E 809 X Ye et al., 2017
36 Cornuside F 809 X Ye et al., 2017
37 Cornuside G 809 X Ye et al., 2017
38 Cornuside H 809 X Ye et al., 2017
39 Cornuside I 809 X Ye et al., 2017
40 Cornuside J 809 X Ye et al., 2017
41 Cornuside K 823 X Ye et al., 2017
42 Cornuside L 779 X Ye et al., 2017
43 Cornuside M 779 X Ye et al., 2017
44 Cornuside N 779 X Ye et al., 2017
45 Cornuside O 779 X Ye et al., 2017
46 Cornuside II 779 X Liu Z. et al., 2011
47 Cornuside III 506 X Wang et al., 2017
48 Cornuside IV 506 X Wang et al., 2017
49 Corniside I 779 X Cao et al., 2012
50 Corniside II 542 X Cao et al., 2011, 2012
51 Williamsoside D 822 X Ye et al., 2017
ANTHOCYANINS
52 Pelargonidin 271 X Sozanski et al., 2016
53 Pelargonidin 3-O-galactoside 433 X X Du and Francis, 1973; Seeram et al., 2002; Jayaprakasam
et al., 2006; Vareed et al., 2006; Sozanski et al., 2014, 2016;
Kucharska et al., 2015
54 Pelargonidin 3-O-glucoside 433 X Jayaprakasam et al., 2005; Tural and Koca, 2008;
Pawlowska et al., 2010; Capanoglu et al., 2011;




579 X Du and Francis, 1973; Sozanski et al., 2014, 2016;
Kucharska et al., 2015; Antolak et al., 2017
56 Pelargonidin 3-O-rutinoside 579 X Pawlowska et al., 2010
57 Cyanidin 287 X Sozanski et al., 2016
58 Cyanidin 3-O-galactoside 449 X X Du and Francis, 1973; Seeram et al., 2002; Jayaprakasam
et al., 2005, 2006; Vareed et al., 2006; Pawlowska et al.,
2010; Begic-Akagic et al., 2013; Drkenda et al., 2014;
Sozanski et al., 2014, 2016; Kucharska et al., 2015;
Milenkovic´-Andjelkovic´ et al., 2015





595 X Du and Francis, 1973; Sozanski et al., 2014, 2016;
Kucharska et al., 2015; Antolak et al., 2017
61 Cyanidin 3-O-rutinoside 595 X Du and Francis, 1973; Tural and Koca, 2008; Capanoglu
et al., 2011; Begic-Akagic et al., 2013; Drkenda et al., 2014
62 Peonidin 3-O-glucoside 464 X Begic-Akagic et al., 2013; Drkenda et al., 2014
63 Delphinidin 3-O-glucoside 465 X Jayaprakasam et al., 2005
64 Delphinidin 3-O-galactoside 465 X X Du and Francis, 1973; Seeram et al., 2002; Jayaprakasam
et al., 2006; Vareed et al., 2006; Sozanski et al., 2014, 2016;
Kucharska et al., 2015; Milenkovic´-Andjelkovic´ et al., 2015
65 Petunidin 3-glucoside 479 X Antolak et al., 2017
(Continued)
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C. mas C. officinalis References
FLAVONOIDS
Flavonols
66 Quercetin 302 X X Kim and Kwak, 1998; Xie et al., 2012; Radovanovic´ et al.,
2013; Drkenda et al., 2014; Ma et al., 2014; Sochor et al.,
2014; Antolak et al., 2017; Cosmulescu et al., 2017
67 Quercetin 3-O-β-D-xyloside
(avicularin)




448 X Pawlowska et al., 2010; Begic-Akagic et al., 2013; Drkenda
et al., 2014; Sochor et al., 2014; Popovic´ et al., 2017;
Bajic´-Ljubicˇic´ et al., 2018
69 Quercetin 3-O-β-D-glucoside
(isoquercetin, isoquercitrin)
464 X X Pawlowska et al., 2010; Liu Z. et al., 2011; Xie et al., 2012;
Begic-Akagic et al., 2013; Drkenda et al., 2014; Ma et al.,
2014; Milenkovic´-Andjelkovic´ et al., 2015; Antolak et al.,
2017; Popovic´ et al., 2017; Bajic´-Ljubicˇic´ et al., 2018
70 Quercetin 3-O-β-D-galactoside
(hyperoside)
464 X X Pawlowska et al., 2010; Xie et al., 2012; Begic-Akagic et al.,
2013; Drkenda et al., 2014; Ma et al., 2014;
Milenkovic´-Andjelkovic´ et al., 2015; Popovic´ et al., 2017;
Bajic´-Ljubicˇic´ et al., 2018
71 Quercetin 3-O-β-D-glucuronide
(querciturone)
478 X X Pawlowska et al., 2010; Lin et al., 2011; Liu Z. et al., 2011;
Popovic´ et al., 2017; Bajic´-Ljubicˇic´ et al., 2018
72 Quercetin 3-O-rutinoside (rutin) 610 X Pawlowska et al., 2010; Begic-Akagic et al., 2013; Deng
et al., 2013; Radovanovic´ et al., 2013; Drkenda et al., 2014;
Sochor et al., 2014; Milenkovic´-Andjelkovic´ et al., 2015;
Rudrapaul et al., 2015; Cosmulescu et al., 2017; Popovic´
et al., 2017; Bajic´-Ljubicˇic´ et al., 2018
73 Quercetin 3-O-robinobioside 610 X Begic-Akagic et al., 2013; Drkenda et al., 2014
74 Quercetin 3-O-β-D-glucuronide
methyl ester





534 X Lin et al., 2011
76 Kaempferol 286 X Kim and Kwak, 1998; Xie et al., 2012
77 Kaempferol 3-O-β-D-galactoside
(trifolin)
448 X X Pawlowska et al., 2010; Ma et al., 2014
78 Kaempferol 3-glucoside 448 X Begic-Akagic et al., 2013; Drkenda et al., 2014;
Milenkovic´-Andjelkovic´ et al., 2015
79 Kaempferol 3-O-β-D-rutinoside 594 X Ma et al., 2014
80 4′-Methylkaempferol
(kaempferide)
300 X Xie et al., 2012
81 Myricetin 318 X Rudrapaul et al., 2015; Cosmulescu et al., 2017
82 Myricetin 3-galactoside 480 X Antolak et al., 2017
83 2R, 3R-trans-Aromadendrin 288 X Rudrapaul et al., 2015
84 Aromadendrin
7-O-β-D-glucoside (sinensin)
450 X Pawlowska et al., 2010
85 Naringenin 7-O-methylether 286 X Rudrapaul et al., 2015
86 7,3′-Dihydroxy-5,4′-
dimethoxyflavanone




376 X Rudrapaul et al., 2015
Flavan-3-ols
88 (+) Catechin 290 X Radovanovic´ et al., 2013; Milenkovic´-Andjelkovic´ et al., 2015
(Continued)
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C. mas C. officinalis References
89 (-) Epicatechin 290 X Radovanovic´ et al., 2013; Milenkovic´-Andjelkovic´ et al., 2015;
Cosmulescu et al., 2017
90 (-) Epicatechin-3-O-gallate 442 X Lin et al., 2011
91 Procyanidin B1 578 X Begic-Akagic et al., 2013; Drkenda et al., 2014
92 Procyanidin B2 578 X Begic-Akagic et al., 2013; Radovanovic´ et al., 2013; Drkenda
et al., 2014; Milenkovic´-Andjelkovic´ et al., 2015
PHENOLIC ACIDS
93 Gallic acid 170 X X Tian et al., 2000; Du et al., 2008; Cao et al., 2011; Lin et al.,
2011; Liu Z. et al., 2011; Cao et al., 2012; Youn and Jun,
2012; Cai et al., 2013; Deng et al., 2013; Radovanovic´ et al.,
2013; Sochor et al., 2014; Milenkovic´-Andjelkovic´ et al.,
2015; Rudrapaul et al., 2015; Jiang et al., 2016; Antolak
et al., 2017; Cosmulescu et al., 2017
94 Caffeic acid 180 X X Lin et al., 2011; Radovanovic´ et al., 2013; Ma et al., 2014;
Cosmulescu et al., 2017
95 p-Coumaric acid (coumaric acid) 164 X X Youn and Jun, 2012; Radovanovic´ et al., 2013; Antolak et al.,
2017; Cosmulescu et al., 2017
96 Ellagic acid 302 X X Cao et al., 2012; Milenkovic´-Andjelkovic´ et al., 2015;
Cosmulescu et al., 2017
97 Protocatechuic acid 154 X X Liu Z. et al., 2011; Antolak et al., 2017
98 Benzoic acid 122 X Krivoruchko, 2014
99 Cinnamic acid (trans-cinnamic
acid)
148 X Antolak et al., 2017; Cosmulescu et al., 2017
100 Ferulic acid 194 X Krivoruchko, 2014; Antolak et al., 2017; Cosmulescu et al.,
2017
101 Sinapic acid 224 X Cosmulescu et al., 2017
102 Salicylic acid 138 X Krivoruchko, 2014; Cosmulescu et al., 2017
103 Syringic acid 198 X Radovanovic´ et al., 2013; Cosmulescu et al., 2017
104 Vanillic acid 168 X Krivoruchko, 2014; Cosmulescu et al., 2017
105 Rosmarinic acid 360 X Antolak et al., 2017
106 Chlorogenic acid 354 X Begic-Akagic et al., 2013; Deng et al., 2013; Drkenda et al.,
2014; Sochor et al., 2014; Milenkovic´-Andjelkovic´ et al.,
2015; Cosmulescu et al., 2017
107 Neochlorogenic acid 354 X Popovic´ et al., 2017; Bajic´-Ljubicˇic´ et al., 2018




318 X Ma et al., 2014
110 Caffeoyltartaric acid dimethyl
ester
340 X Park et al., 2016
111 Caftaric acid monomethyl ester 326 X Lin et al., 2011
TRITERPENOIDS
112 Ursolic acid 456 X X Jayaprakasam et al., 2006; Wang H. et al., 2008; Yu et al.,
2009; Youn and Jun, 2012; He et al., 2016
113 Oleanolic acid 456 X Wang H. et al., 2008; Lin et al., 2011
114 Arjunglucoside I 666 X Liu Z. et al., 2011
115 Arjunglucoside II 650 X Liu Z. et al., 2011
CARBOHYDRATES
116 Calcium pectate – X Bilejic´ et al., 2011; Jac´imovic´ et al., 2015
117 FCAP1 – X Yang et al., 2010
118 PFCC-I 75,700 X Li et al., 2012
119 PFCA-III 17,400 X Li et al., 2012
(Continued)
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C. mas C. officinalis References
TANNINS
120 7-O-galloyl-D-sedoheptulose 362 X Yamabe et al., 2009; Yokozawa et al., 2010; Liu Z. et al.,
2011; Park et al., 2015
121 2,3-Di-O-galloyl-β-D-glucose 484 X Okuda et al., 1984; Hatano et al., 1989a; Cao et al., 2011,
2012
122 1,7-Di-O-galloyl-D-glucose 484 X Liu Z. et al., 2011
123 1,2,3-Tri-O-galloyl-β-D-glucose 636 X Hatano et al., 1989a; Cao et al., 2011, 2012; Bhakta et al.,
2017
124 1,2,6-Tri-O-galloyl-β-D-glucose 636 X Okuda et al., 1984; Hatano et al., 1989a
125 1,2,3,6-Tetra-O-galloyl-β-D-
glucose
788 X Okuda et al., 1984; Hatano et al., 1989a, 1990; Cao et al.,
2011, 2012; Bhakta et al., 2017
126 Tellimagrandin I 786 X Okuda et al., 1984; Hatano et al., 1989a; Cao et al., 2012;
Bhakta et al., 2017
127 Tellimagrandin II
(tellimagrandin-α, eugeniin)
938 X Okuda et al., 1984; Hatano et al., 1989a, 1990; Cao et al.,
2011, 2012; Bhakta et al., 2017
128 Cornusiin A 1,571 X Okuda et al., 1984; Hatano et al., 1989a
129 Cornusiin B 1,087 X Okuda et al., 1984; Hatano et al., 1989a
130 Cornusiin C 2,572 X Hatano et al., 1989a
131 Cornusiin D 1,722 X Hatano et al., 1989b
132 Cornusiin E 1,875 X Hatano et al., 1989b
133 Cornusiin F 2,202 X Hatano et al., 1989b
134 Cornusiin G 1,725 X Hatano et al., 1990
135 Camptothin A 1,419 X Hatano et al., 1989b
136 Camptothin B 1,723 X Hatano et al., 1989b
137 Gemin D (3-O-galloyl-4,6-(S)-
hexahydroxydiphenoyl-D-
glucose)
634 X Okuda et al., 1984; Hatano et al., 1989a
138 Oenothein C 784 X Okuda et al., 1984; Hatano et al., 1989a
139 Isoterchebin 955 X Okuda et al., 1981, 1984; Hatano et al., 1989a; Bhakta et al.,
2017
CAROTENOIDS
140 (13Z)+(13′Z)-Lutein 568 X Horváth et al., 2007
141 (9Z)+(9′Z)-Lutein 568 X Horváth et al., 2007
142 (9′Z)-Neoxanthin 601 X Horváth et al., 2007
143 (E)-Neoxanthin 601 X Horváth et al., 2007
144 Lutein-5,6-epoxide 585 X Horváth et al., 2007
145 Luteoxanthin (epimers) 601 X Horváth et al., 2007
146 Neochrome (epimers) 553 X Horváth et al., 2007
147 β-carotene 537 X Horváth et al., 2007
148 β-carotene-5,6-monoepoxide 553 X Horváth et al., 2007
149 β-cryptoxanthin 553 X Horváth et al., 2007
FATTY ACIDS
150 Behenic acid 340 X Krivoruchko, 2014
151 Lauric acid 200 X Brindza, 2009; Krivoruchko, 2014
152 Linoleic acid 280 X Brindza, 2009; Krivoruchko, 2014
153 Linolenic acid 278 X Brindza, 2009; Krivoruchko, 2014
154 Myristic acid 228 X Brindza, 2009
155 Oleic acid 282 X Brindza, 2009; Krivoruchko, 2014
156 Palmitic acid 256 X Brindza, 2009; Krivoruchko, 2014
157 Plamitoleic acid 254 X Brindza, 2009; Krivoruchko, 2014
158 Pentadecenic acid 240 X Brindza, 2009
159 Pentadecanoic acid 242 X Krivoruchko, 2014
(Continued)
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C. mas C. officinalis References
160 Stearic acid 284 X Brindza, 2009; Krivoruchko, 2014
161 Vaccenic acid 282 X Brindza, 2009




126 X Du et al., 2008; Yokozawa et al., 2010; Cao et al., 2011,
2012; Cai et al., 2013; Jiang et al., 2016
164 Dimethyltetrahydrofuran
cis-2,5-dicarboxylate
188 X Kim and Kwak, 1998
165 β-sitosterol 415 X Lin et al., 2011
166 Daucosterol-6′-malate 692 X Xie et al., 2012
167 (1′S, 2′R)-guaiacyl glycerol
3′-O-β-D-glucoside
376 X Ma et al., 2014
168 Mevaloside 292 X Yokozawa et al., 2010
169 2,7-Anhydro-D-sedoheptulose
(sedoheptulosan)
192 X Liu Z. et al., 2011
170 Resveratrol 228 X Sochor et al., 2014
171 Malic acid 134 X X Cao et al., 2012; Begic-Akagic et al., 2013; Deng et al., 2013;
Drkenda et al., 2014; Krivoruchko, 2014
172 Malic acid methyl ester 148 X Cao et al., 2011, 2012
173 Dimethyl malate 162 X Miyazawa et al., 2003
174 Tartaric acid 150 X X Cao et al., 2012; Begic-Akagic et al., 2013; Deng et al., 2013;
Drkenda et al., 2014
175 Butoxysuccinic acid 190 X Lin et al., 2011
176 Citric acid 192 X Begic-Akagic et al., 2013; Deng et al., 2013; Drkenda et al.,
2014
177 Succinic acid 118 X Zhang Q. C. et al., 2013
as well as in the biosynthesis of secoiridoids glucosides and indole
alkaloids. The cyclization to a hemiacetal is likely to take place
through the incorporation of an oxygen function into the C-8
position of secologanin (27) derived from loganin (1) to generate
further iridoid derivatives (Inouye et al., 1974). Secoiridoids are
believed to be even more advanced due to the more complicated
biostynthetic steps (Xiang et al., 1996). Thus, the most closely
related in the iridoids transformation pathway compounds, such
as loganin (1), loganic acid (3), cornin (4), sweroside (5), and
representative of secoiridoids, cornuside (6), have been detected
both in fruits of C. mas and C. officinalis (Deng et al., 2013; Ma
et al., 2014; Perova et al., 2014; Sochor et al., 2014; Kucharska
et al., 2015; Jiang et al., 2016). However, it should be noted that
in the 26 cultivars of C. mas it was shown that the most abundant
iridoid was loganic acid (3) (81.5–461.1mg/100 g fw) constituting
88–96% of total iridoids (86.9–493.7 mg/100 g fw). Cornuside
(6) has already followed loganic acid (3) but its content was
much lower than loganic acid (3) and maximally reached 36.2
mg/100 g fw (West et al., 2012a; Kucharska et al., 2015). Only two
reports describe the identification of loganin (1) and sweroside
(5) in fruit of C. mas (Deng et al., 2013; Perova et al., 2014).
Nevertheless, the reason of limited data on identification of
loganin and sweroside in fruits of cornelian cherry is due to
their low concentration compared to loganic acid. More detailed
studies are needed in this field.
Anthocyanins
The mature fruits from both C. mas and C. officinalis are dark red
colored and for this reason they might be easily confused. Thus,
in addition to iridoids (Figures 1, 2), anthocyanins (Figure 3),
red colorant compounds, are widely distributed in fruits of these
dogwoods. The content of anthocyanins increases when the fruits
change their color from light yellow to dark red (Gunduz et al.,
2013). Fruits of cornelian cherry and Asiatic dogwood contain in
particular pelargonidin (52) and cyanidin (57) derivatives. Both
in C. mas and C. officinalis pelargonidin 3-O-galactoside (53),
cyanidin 3-O-galactoside (58), and delphinidin 3-O-galactoside
(64) were detected and quantified. Pelargonidin 3-O-galactoside
(53) (1.62 mg/g) and cyanidin 3-O-galactoside (58) (1.66 mg/g)
have been noted as the most abundant anthocyanins of C. mas
fresh fruit (Jayaprakasam et al., 2006; Vareed et al., 2006; Sozanski
et al., 2014; Kucharska et al., 2015). The amount of pelargonidin
3-O-galactoside (53) in fruit of C. officinalis (0.78 mg/g) was
approximately half of the concentration determined in fruit of
C. mas. The other detected anthocyanins of C. officinalis fruit
were present even at lower concentrations (0.15–0.21 mg/g;
Vareed et al., 2006). In the literature, more attention has been
focused on anthocyanins of C. mas (Pantelidis et al., 2007;
Popovic´ et al., 2012; Bilejic´ et al., 2015; Kucharska et al.,
2015). These pigments were identified using methods such as
HPLC, LC-ES/MS and NMR (Seeram et al., 2002; Kucharska
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FIGURE 3 | The chemical structures of anthocyanins, flavonoids, and phenolic acids identified in fruits of C. mas and/or C. officinalis.
et al., 2015), HPLC (Tural and Koca, 2008; Capanoglu et al.,
2011) and LC-PDA-MS (Pawlowska et al., 2010). In some
cultivars of the southeastern Europe peonidin 3-O-glucoside
(62) followed by cyanidin 3-O-galactoside (58) was established
as the major constituent of C. mas fruits (Drkenda et al.,
2014).
Flavonoids
Cornus species have been proven to contain flavonols mostly
quercetin (66) and kaempferol (76) derivatives (Figure 3). Most
of reported compounds were identified as monoglycosides
containing glucose, galactose, rhamnose, and glucuronic acid
as a sugar moiety. The quercetin glycosides (69–71) as well as
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FIGURE 4 | The chemical structures of phenolic compounds and terpenoids identified in fruits of C. mas and/or C. officinalis.
kaempferol 3-O-β-D-galactoside (77) were determined in both
species (Pawlowska et al., 2010; Xie et al., 2012; Ma et al., 2014).
The trace amounts of aglycone of flavonols such as quercetin (66)
was found in fruits of both C. mas and C. officinalis (Xie et al.,
2012; Rudrapaul et al., 2015).
Phenolic Acids
Three different groups of phenolic acids (Figure 3), including
benzoic acid, trans-cinnamic acid and ellagic acid derivatives
have been described in the fruits of C. mas and C. officinalis.
The typical representatives of each group such as gallic acid
(93), caffeic acid (94), p-coumaric acid (95), ellagic acid (96),
and protocatechuic acid (97) have been found in both dogwoods
(Liu Z. et al., 2011; Cao et al., 2012; Radovanovic´ et al., 2013;
Milenkovic´-Andjelkovic´ et al., 2015; Rudrapaul et al., 2015;
Antolak et al., 2017; Cosmulescu et al., 2017). Ellagic acid (96),
which is a marker of ellagitannins occurrence, detected in the
fruits of cornelian cherry suggests the presence of ellagitannins
in this plant material. However, this hypothesis requires further
investigation.
Triterpenoids
Additionally, some other compounds such as triterpenoids
(Figure 4) and carbohydrates have been identified in both
species. Among terpenoids only ursolic acid (112) has been
reported in the fruits of cornelian cherry and Asiatic dogwood
(Jayaprakasam et al., 2006; Wang H. et al., 2008; Jang et al.,
2014; He et al., 2016). This compound was often reported
as an active constituent found in ethanolic and methanolic
extracts from fruits of C. officinalis (Gao et al., 2008). In
addition, other three triterpenoid acids (113–115), including
oleanolic acid, have been identified inC. officinalis (Jayaprakasam
et al., 2006; Wang H. et al., 2008; Jang et al., 2014; He et al.,
2016).
Carbohydrates
Carbohydrates are the crucial compounds determining the
quality of fruits due to the fact that the sugar content is a
major parameter affecting a direct consumption of fruits in
addition to food preservation aspects (Çopur et al., 2003; Brindza,
2007; Bilejic´ et al., 2011, 2015). Thus, monosaccharides and
polysaccharides are present in the fruits of both species. The
fruits of C. mas contain the atypical fibers such as calcium
pectate (116) (1.31%; Bilejic´ et al., 2011; Jac´imovic´ et al., 2015).
The crude fiber (0.36–0.76%) and total pectin (0.26–1.04%)
contents were evaluated in C. mas fruits grown in different
regions of Europe (Çopur et al., 2003; Sochor et al., 2014).
Therefore, the juice of C. mas is considered an alternative
fermentation substrate for the production of functional beverage.
The simultaneous decreasing total sugars content and increasing
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contents of lactic and acetic acids were studied in the juice as
well as unripe cornelian cherries fruits fermented by Lactobacillus
sp. (Nouska et al., 2016; Czyzowska et al., 2017). It is worth to
note that fermented cornelian cherry-derived products of iridoid
glycosides and phenolic acids may complement gut microbiota
and in this manner play a role of new probiotic functional
products (Czyzowska et al., 2017). Additionally, the fibers and
particularly oligosaccharides, which are generally found in fruits,
are considered the non-digestible food ingredient stimulating
the growth or selective activity of gut microbiota (Gibson,
2008). The dietary fiber in both cornelian cherries (Nawirska-
Olszanska et al., 2010) and cornel dogwood fruits (Shao, 2011)
is the important constituent of a diet determining human well-
being due to a wide range of metabolic health benefits such as
reduction of cholesterol level, blood pressure and body weight.
Thus, the potential prebiotic activity of constituents such as
dietary fiber from fruits of both dogwoods should not be
excluded. On the other hand, a purification and isolation of
bioactive polysaccharides of C. officinalis fruit (Yang et al., 2010;
Li et al., 2012; You et al., 2013; Yin et al., 2016) have been
also shown. The list of polysaccharides (117–119) identified in
the fruits of C. officinalis is presented in Table 1. The most
abundant monosaccharide components of these polysaccharides
were glucose, rhamnose and arabinose (Yang et al., 2010; Li
et al., 2012). The monosaccharide profile of C. mas fruits have
been represented by glucose, fructose and sucrose (Bilejic´ et al.,
2011; Perova et al., 2014; Tarko et al., 2014; Antolak et al.,
2017).
Differences in Chemical Composition
General
Despite a wide range of similarities and close phylogenetic
relationship of C. mas and C. officinalis, few differences
in chemical composition of fruits can be found. The most
valuable characteristic established only in fruits of C. officinalis
seems to be the presence of tannins (120–139) as well as
unique iridoids. Morroniside (8) is one of the most important
iriodid glucoside reported in the fruits of C. officinalis.
Additionally, 43 other iridoids (9–51) have been identified in
this plant material. It should be underlined that co-existence
of iridoids and tannins seems to be very rare in plants.
Furthermore, 5-hydroxymethylfurfural (163) and steroids, such
as β-sitosterol (165) and daucosterol-6′-malate (166) are unique
for C. officinalis.
On the other hand, flavan-3-ols derivatives, such as
procyanidin B1 (91) and B2 (92), carotenoids (140–149)
and fatty acids (150–162) have been identified only in fruits of
C. mas. It is worth to note that many reports provide data on
ascorbic acid or pectin content in fruits of C. mas due to their
dietary role. As far as the Asiatic dogwood is concerned, these
data are completely missed.
The one comparative study on quantities of secondary
metabolites in aqueous extracts from leaves of C. mas
and C. officinalis have revealed that extracts of C. mas are
characterized by lower content of flavonoids, hydroxycinnamic
acids, total polyphenols and tannins than extracts of C. officinalis
(Forman et al., 2015). On the other hand, no comparative
quantitation of major secondary metabolites, except for
anthocyanins (Seeram et al., 2002; Vareed et al., 2006) of
dogwood fruits is available to date. Thus, further comparative
elucidation of chemical composition as well as quantification
of phytochemicals in fruits of both species still seem to be a
challenge.
Unique Iridoids of C. officinalis
Although iridoids were classified as similar characteristic for
both species, much more not widely known iridoids have been
found only in fruits of C. officinalis. In particular, in contrary
to the cornelian cherry fruits the major iridoid constituents of
Asiatic dogwood fruits were isomers of α and β of morroniside
(8) as well as their methyl and ethyl derivatives (9–15) (Du
et al., 2008; West et al., 2012a,b; Xie et al., 2012; Jiang et al.,
2016; Park et al., 2016; Ji et al., 2017). Additionally, apart from
typical iridoids described previously, less-known compounds
such as logmalicids A and B (19–20) as well as cornusfurosides
A-D (22–24) were found in fruits of C. officinalis (Ma et al.,
2014; He et al., 2017). Fifteen rare iridoid glucoside dimers,
named cornusides A-O (31–45) (Figure 2), have been isolated
from an aqueous extract of C. officinalis fruits (Ye et al.,
2017).
Tannins of C. officinalis
Similarly, tannins are attributed only to the fruits of C. officinalis
and have been widely described. Therefore, tannins (Figures 5, 6)
in the fruits of C. officinalis constitute the most important
difference between both plant materials. Despite the mean
content of tannins in fruits of C. mas was established as 0.34%
(Gunduz et al., 2013), the detailed reports on the identification
of tannins in the fruits of C. mas have been limited in contrary
to C. officinalis. The Asiatic dogwood is particularly considered
a rich source of hydrolyzable tannins (Okuda et al., 1981,
1984). Twenty tannins (120–139), including ellagitannins and
gallotannins, have been described in C. officinalis. The derivatives
of galloylglucose (121–125), particularly digalloylglucose, have
been identified to date. Tellimagrandin I (126) and II (127) as
well as gemin D (137) and oenothein C (138) are representative
of ellagitannins (Okuda et al., 1981, 1984; Lee et al., 1989;
Cao et al., 2012; Bhakta et al., 2017). Most of unique dimeric
and trimeric hydrolyzable tannins named cornusiins A–G (128–
134) have been found only in the fruits of C. officinalis to
date (Okuda et al., 1984; Hatano et al., 1989a,b, 1990). One
of the bioactive constituents which should be mentioned due
to the fact of potential biological activity is also 7-O-galloyl-D-
sedoheptulose (120) (Yamabe et al., 2009; Yokozawa et al., 2010;
Liu Z. et al., 2011; Park et al., 2015). It is worth to note that
some tannins were detected in the fruits of cornelian cherry
(Kucharska, 2012). However, their detailed identification was not
conducted, and in fact the data concerning tannins in C. mas are
not available.
Carotenoids and Fatty Acids of C. mas
Some lipophilic compounds such as carotenoids as well as fatty
acids have been identified in the fruits of C. mas in contrast
to C. officinalis. One report showed the determination of ten
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FIGURE 5 | The chemical structures of tannins identified in fruits of C. officinalis.
carotenoids (140–149) in the fruits of C. mas (Horváth et al.,
2007), in addition to their quantitation in fresh and dried fruits
(Rosu et al., 2011; Lofti et al., 2014). Carotenoids are believed
to be regulators of lipid metabolism and antioxidants. Among
carotenoids the most abundant in a diet is β-carotene (147),
known singlet oxygen quencher and precursor for vitamin A
(Grune et al., 2010). Despite limited data on this group of
compounds in fruits of C. mas, their potential role in biological
effectiveness of C. mas fruits should be considered. To the best of
our knowledge there is no report on carotenoids in C. officinalis.
Similarly, the available data on fatty acids in the fruits of Asiatic
dogwood have been limited and the detailed analysis seems to be
necessary. Fatty acids (150–162) such as linoleic acid (152), oleic
acid (155) and palmitic acid (156) have been the most abundant
in the fruits of C. mas (Krivoruchko, 2014).
Diversity of Phenolic Compounds in C. mas and
C. officinalis
Nine quercetin derivatives (67–75) have been identified in
the fruits of C. mas (Pawlowska et al., 2010). Simultaneously,
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FIGURE 6 | The chemical structures of tannins (continued) identified in fruits of C. officinalis.
kaempferol 3-O-β-D-galactoside (77), myricetin (81), and
naringenin 7-O-methylether (85) have been detected in the fruits
of C. mas along with 7,3′-dihydroxy-5,4′-dimethoxyflavanone
(86) (Pawlowska et al., 2010; Rudrapaul et al., 2015). It is
worth to note that 2R, 3S-trans-aromadendrin (83) and its 7-
O-β-D-glucoside (84), which are not so widely distributed in
plants compared to quercetin and kaempferol glycosides, were
determined in the fruits of C. mas (Pawlowska et al., 2010;
Rudrapaul et al., 2015). On the other hand, some glycosides, such
as quercetin 3-O-β-D-glucuronide methyl ester (74), quercetin
3-O-β-D-(6′′-n-butyl glucuronide) (75), kaempferol 3-O-β-D-
rutinoside (79) as well as kaempferide (80) have been reported
in fruits of C. officinalis according to the available literature (Lin
et al., 2011; Xie et al., 2012; Ma et al., 2014).
Flavan-3-ols such as catechin (88) and epicatechin (89)
have been identified and quantified in the fruits of C. mas
(Capanoglu et al., 2011; Milenkovic´-Andjelkovic´ et al., 2015).
In the study of Milenkovic´-Andjelkovic´ et al. (2015), catechin
(88) was the predominant favan-3-ol in the fruit extracts
of C. mas (Figure 3). Additionally, procyanidin B2 (92) was
found only in the fruit extracts of C. mas (Radovanovic´
et al., 2013; Milenkovic´-Andjelkovic´ et al., 2015). The degree
of polymerization in the fruits of cornelian cherry was assessed
at the level of 63 total bound (epi)catechin units/end units
(Capanoglu et al., 2011).
The mixture of benzoic acid (98) and cinnamic acid (99)
derived phenolic acids, including ferulic acid (100), sinapic acid
(101) as well as vanillic acid (104), was identified in the fruits
of C. mas (Radovanovic´ et al., 2013; Milenkovic´-Andjelkovic´
et al., 2015; Rudrapaul et al., 2015; Cosmulescu et al., 2017).
In addition, the esters formed between phenolic acids’ particles,
such as rosmarinic acid (105) and chlorogenic acid (106) have
been found only in the fruits of cornelian cherry (Figure 4;
Deng et al., 2013; Antolak et al., 2017; Popovic´ et al., 2017;
Bajic´-Ljubicˇic´ et al., 2018). The unique derivatives of phenolic
acids such as tachioside (108), caffeoyltartaric acid dimethyl ester
(110), and caftaric acidmonomethyl ester (111) are characteristic
for Asiatic dogwood’s fruits (Figure 4; Lin et al., 2011; Ma et al.,
2014; Park et al., 2016).
Other Constituents
Due to the fact of the usage of C. mas for a production of
concentrates, jams, and even more often fruit juice and alcoholic
beverages, rheological and physicochemical properties related to
the quality of liquid foods have been reported (Güleryüz et al.,
1998; Brindza, 2009; Kalyoncu et al., 2009; Karadeniz et al., 2009;
Yilmaz et al., 2009; Hassanpour et al., 2012; Gastoł et al., 2013;
Bilejic´ et al., 2015; Rad et al., 2016; Bozdogan, 2017). In particular,
apart from titrable acidity, soluble solid content as well as total
sugars and pectin content, vitamin C was often quantified in the
fruits of C. mas. They were characterized by the high content
of ascorbic acid ranging from 43.6 to 76.7 mg/100 g, or even
reaching 112 mg/100 g in Turkish cultivars (Güleryüz et al., 1998;
Çopur et al., 2003; Demir and Kalyoncu, 2003; Brindza, 2007,
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2009; Yalcinkaya et al., 2009; Yilmaz et al., 2009; Rop et al., 2010;
Dokoupil and Reznícˇek, 2012; Hassanpour et al., 2012; Bilejic´
et al., 2015; Kostecka et al., 2017). However, it was noted that
cornelian cherry fruits from Greece were characterized by higher
content of vitamin C than these ones from Poland (Kostecka
et al., 2017). On the other hand, some physicochemical properties
of cornel dogwood wine during its fermentation and storage were
studied once (Zhang Q. -A. et al., 2013).
Few reports considered the potential bioactivity of 5-
hydroxymethylfurfural (163) isolated from fruits of C. officinalis
(Figure 7; Du et al., 2008; Cao et al., 2011, 2012; Jiang et al.,
2016). Additionally, steroid compounds including β-sitosterol
(165) and daucosterol-6′-malate (166) have been identified only
in fruits of C. officinalis (Figure 7; Lee et al., 1989; Lin et al., 2011;
Xie et al., 2012).




Taking into account different medical approaches in the
traditional medicine in ancient Europe and Asia, in particular
China, it is rather interesting that there are some similar
indications reported for both species. They have been
traditionally used to improve liver and kidney functions and
are considered therapeutically usefull due to their antidiabetic
and antimicrobial properties. Considering the phytochemical
similarities between both species the comparable use of
both species is scientifically reasonable. For this reason, the
antidiabetic effect as well as renal and hepatic protective
activities of both species were particularly considered in the
reported studies. In addition, the positive effects on central
nervous and cardiovascular systems of both species have
been noted. The background of these effects seems to be the
antioxidant activity as well as an amelioration of inflammatory
processes through regulation of NF-κB and MAPK signaling
pathways by constituents of extracts from fruits of both
species. The isolated constituents of fruits, such as cornuside
(6), loganin (1), ursolic acid (112), anthocyanins, and more
specific for C. officinalis morroniside (8), and 7-O-galloyl-
D-seduheptulose (120), demonstrated the biological impact.
However, the pharmacological effect of other phytochemicals
found in fruits of both species should not be excluded in the
provided reports. Thus, the accurate qualitative and quantitative
characterization of phytochemicals in extracts is required in
the studies, and the beneficial role of complex phytochemical
formulation providing the synergistic or additive effect should be
underlined.
The antimicrobial and antitumor activities of both species
seem to be mostly related to the presence of polyphenolic
compounds in fruit extracts. However, these activities of both
species do not seem to be well-established.
Table 2 demonstrates similarities and differences of the
biological or pharmacological activities between the preparations
from fruits of both species. The biologically or pharmacologically
active groups of compounds or isolated constituents of fruit
extracts were included in Table 2.
Similar Biological or Pharmacological
Activities of C. mas and C. officinalis
Antidiabetic Effect
Comparing the reported traditional therapeutic use of fruits from
C. mas and C. officinalis it is obvious that the treatment of
metabolic disorders played an important role. Based on different
fundamentals of ancient medicine in China and Europe or
western Asia and despite missing modern diagnostic tools for
precise detection of diabetes, the physicians recognized definitely
metabolic disease in the distant past and tried to treat their
accompanying symptoms. Under this point of view the use
of fruits from both species should be discussed in order to
their potential usefulness in the treatment of metabolic diseases
in different geographic regions. Due to the wide spectrum of
natural compounds and modern investigations of their biological
activity an antidiabetic effect of cornelian cherry seems to be
proven. Based on some animal experiments investigating the
effect of preparations made from C. mas fruits the blood glucose
decreasing activity and enhancement of insulin sensitivity were
demonstrated (Jayaprakasam et al., 2006; Mirbadalzadeh and
Shirdel, 2012; Narimani-Rad et al., 2013; Asgary et al., 2014).
The same findings were reported also for fruits of C. officinalis
(Park et al., 2011; Gao et al., 2012; Liu et al., 2012; Han et al.,
2014). Data from clinical studies evaluating the therapeutic effect
of the herbal preparation are available only for C. mas. One
study on the fruit extract showed its antidiabetic effect associated
with the reduction of risk factors for secondary diseases (Soltani
et al., 2015). Comparing the chemical constituents present
in both species and their biochemical or pharmacological
effects some similarities can be seen. In the extract of both
species polyphenolic compounds (e.g., flavonoids, anthocyanins),
which inhibit α-glucosidase activity combined with decreasing
postprandial blood glucose level, are present (Park et al., 2011;
Asgary et al., 2014; Shishehbor et al., 2016). Ursolic acid (112)
also present in both species is capable to stimulate the glucose
uptake through the phosphorylation of insulin receptor (Zhang
et al., 2006). Specific antidiabetic effects were reported for 7-
O-galloyl-D-seduheptulose (120) and iridoids [e.g., loganin (1),
morroniside (8)] present in C. officinalis (Yamabe et al., 2009;
Park et al., 2010, 2013; He et al., 2016) as well as for cyanidin
3-O-galactoside (58) and cyanidin 3-O-glucoside (59) present in
C. mas (Jayaprakasam et al., 2005). On the other hand, loganin
(1) and ursolic acid (112) were not able to affect an expression of
phosphoenolpyruvate carboxykinase (PEPCK) in rat hepatoma
H4IIE cell line on the contrary methanolic extract of C. officinalis
fruit (50µg/ml) which exerted insulin mimetic effect in this
manner, and one of its fraction enhanced insulin secretion by rat
insulin-secreting BRIN-BD11 cells in response to high glucose
concentration (16.7mM; Chen et al., 2008). Although there is
only one published clinical study of the fruit extract from C. mas
the antidiabetic effect seems to be proven (Soltani et al., 2015).
The prolonged high blood glucose concentration leads
to progressive lesions in heart, kidney, blood vessels and
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FIGURE 7 | The chemical structures of other compounds identified in fruits of C. mas and/or C. officinalis.
other organs. Moreover, increased intracellular reducing
sugars and their derivatives may participate in glycation
and formation of advanced glycation endproducts (AGEs)
which play an important role in further development of
chronic diabetic complications, atherosclerosis and aging
process. The phytochemicals of C. officinalis fruits such as
gallotannins, particularly 7-O-galloyl-D-sedopheptulose (120),
and morroniside (8) inhibited AGE formation or inhibited
expression of receptors for AGEs (Yamabe et al., 2009; Lee et al.,
2011; Park et al., 2012b, 2015; Lv et al., 2016). Due to the series of
diabetes type II complications, the inhibition of AGE formation
seems to be a promising target for therapeutic intervention
supporting the AGE-related disorders.
Antioxidant Activity
In addition to the studies of total phenolic, flavonoid, and
anthocyanins content, antioxidant properties of the extracts
from cornelian cherries were determined in a correlation
with these phytochemicals. Apart from polyphenols, ascorbic
acid and carotenoids in C. mas play a significant antioxidant
role. Thus, both antioxidants content and antioxidant capacity
of dogwoods fruits are factors determining the quality of
cultivars and basic physicochemical properties. In vitro assays
such as free radical scavenging with DPPH (2,2-diphenyl-1-
picrylhydrazyl radical), ferric ion reducing antioxidant power
(FRAP), total antioxidant capacity with ABTS+ (2,2-azinobis(3-
ethylbenzothiazoline-6-sulfonic acid) radical cation) and oxygen
radical absorbance capacity (ORAC) were the most frequently
used methods in a wide range of studies on C. mas (Dragovic´-
Uzelac et al., 2007; Pantelidis et al., 2007; Hamid et al., 2011;
Celep et al., 2012; Popovic´ et al., 2012; Gunduz et al., 2013;
Pyrkosz-Biardzka et al., 2014; Stankovic et al., 2014; Milenkovic´-
Andjelkovic´ et al., 2015; Hosu et al., 2016; Moldovan et al.,
2016) and C. officinalis (Lee et al., 2006; West et al., 2012a;
Hwang et al., 2016). Moreover, the hydromethanolic extracts of
some cornelian cherry fruit cultivars from Turkey demonstrated
significant H2O2 scavenging activity (79.1%; Ersoy et al., 2011).
Galactosides of cyanidin (58) and pelargonidin (53) detected
in both species inhibited lipid peroxidation by 70.2 and 40.3%
in an iron-catalyzed liposomal model, respectively (Seeram
et al., 2002). On the other hand, the antioxidant properties,
including protection of catalase and glutathione peroxidase,
of C. officinalis fruits are also assigned to polysaccharides (Li
et al., 2012; Wu et al., 2013) and ursolic acid (Yu et al.,
2009).
Anti-inflammatory Activity
Anti-inflammatory and analgesic activities of extracts are
reported for both species. Asmentioned beforemost of the results
were obtained in cell culture or biochemical experiments. The
beneficial effect of aqueous extract from fruits of C. officinalis
and its iridoid constituent cornuside (6) on protein expression
of COX-1 and COX-2 as well as PGE2 production in LPS-
induced macrophages RAW 264.7 was shown (Sung et al., 2009;
Choi et al., 2011). Similarly, ursolic acid (112), which was
isolated from an ethanolic extract of C. officinalis inhibited NF-
κB activation in LPS-stimulated peritoneal macrophages. Oral
administration of ursolic acid (112) significantly inhibited 2,4,6-
trinitrobenzenesulfonic acid (TNBS)-induced colon shortening
and MPO activity in mice, and also suppressed TNBS-induced
COX-2 and iNOS expression as well as NF-κB activation
in colon tissues. Ursolic acid (112) may ameliorate colitis
by regulating NF-κB and MAPK signaling pathways via the
inhibition of LPS binding to toll-like receptors 4 (TLR4) on
immune cells (Jang et al., 2014). Taking into consideration a
wide range of ingredients and general mechanisms responsible
for induction or prevention of inflammation, in vitro results fit
to conclusions obtained from animal experiments and a clinical
study (Sung et al., 2009; Sozanski et al., 2014, 2016; Moldovan
et al., 2016). In particular, cornuside (6) was indicated as an
immunomodulatory dogwood-derived compound in a model
of sepsis in rats (Jiang et al., 2009). The link between chronic
inflammation and cancer involves cytokines and mediators of
inflammatory pathways. Plants contain numerous secondary
metabolites shown to modulate inflammatory pathways. Studies
have shown that these metabolites, among which some
are used in traditional medicine, can reduce inflammation
and carcinogenesis (Desai et al., 2018). Phenolic and other
compounds present in the extracts of the dogwood fruits
target various inflammation-related molecules and pathways
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TABLE 2 | Similarities and differences of the biological or pharmacological activities of fruits from C. mas and C. officinalis.
Biological and pharmacological activities Preparations or characterized natural products responsible for the activity of the fruits
Cornus masa Cornus officinalisb




























Hepatoprotective activity Hydromethanolic extract Aqueous extract






Anticoagulant activity Dried fruits (powder)
Hydromethanolic extract
Not reported




Kidneyprotective activity Hydromethanolic extract Total triterpene acids











Insecticidal activity Not reported Methanolic extract
Antiosteoporotic activity Not reported Aqueous extract
Immunomodulatory activity Not reported Aqueous extract
Ophtalmic activity Anthocyanin-iridoid fraction
Loganic acid
Not reported
aModified according to Dinda et al. (2016) and Hosseinpour-Jaghdani et al. (2017).
bModified according to Huang et al. (2018).
associated with cancer (Choi et al., 2011). Polyphenols modulate
important cellular signaling processes such as NF-κB (nuclear
factor κ light-chain enhancer of activated B cells) activation,
chromatin structure, glutathione biosynthesis, Nrf2 (nuclear
redox factor) activation, direct ROS scavenging or antioxidant
effect via glutathione peroxidase activity. Finally, they regulate
inflammatory genes in macrophages and lung epithelial cells.
Thus, recent data suggest that polyphenols can play a role
of modifiers of signal transduction pathways to elicit their
beneficial effects. However, to correlate this with beneficial effects
in humans their metabolism and bioavailability need to be
considered (Rahman et al., 2006).
Renal and Hepatic Protective Activities
The metabolism of xenobiotics is often linked with the
production of harmful radicals or metabolites damaging such
organs like liver and kidney resulting in inflammation or
carcinogenic transformation. As mentioned before natural
products present in fruits of both species are able to inhibit
both damage generated by radicals and inflammatory processes
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in vitro. Animal experiments performed with methanolic extracts
of C. mas fruits are reported to show hepatoprotective activities
against chemically induced hepatotoxicity after oral application.
The dosage used in the investigations with rats ranging from
200 to 700 mg/kg body weight (Abbasi et al., 2014; Alavian
et al., 2014; Saei et al., 2016). Similar reports concerning C
officinalis are also published (Lee N. H. et al., 2012). The
protective effect on kidneys is described for both species
using comparable animal experimental settings (Yokozawa
et al., 2008; Jiang et al., 2012; Abbasi et al., 2014; Es Haghi
et al., 2014). In particular, the iridoids [loganin (1) and
morroniside (8)] present mainly in the fruits of C. officinalis as
well as 7-O-galloyl-D-sedoheptulose (120) are able to prevent
renal damage in diabetic rats (Xu et al., 2006; Park et al.,
2012a).
Antimicrobial Effect
Antibacterial effects are also reported for extracts of the fruits
from both species without remarkable activity (Mau et al., 2001;
Krzys´ciak et al., 2011; Turker et al., 2012; Radovanovic´ et al.,
2013; Kyriakopoulos and Dinda, 2015; Milenkovic´-Andjelkovic´
et al., 2015; Hosseinpour-Jaghdani et al., 2017). Due to the
presence of a complex of different phenolic compounds in
dogwood fruits the antimicrobial activity is not surprising. All
phenolic compounds to a certain extent express this activity
(Radulovic´ et al., 2013). In addition, it is worth to note that
some phytochemicals of plant materials may reduce the adhesion
of bacteria (Asaia spp.) found in food products/beverages,
as it was shown in the case of juices of cornelian cherry
(Antolak et al., 2017). Thanks to this, the antiadhesive activity
of fruit-derived constituents prevents the formation of biofilm
on the solid surface, which can be potential source of product
contamination. Thus, they are likely to protect both food
and plant preparations used in the phytotherapy against loss
of organoleptic quality manifested by turbidity and flock
formation.
Effects on Memory and Brain Functions
The phytotherapy of diseases or complaints related to the
central nervous systems, including memory retention, has a
long tradition in Asian and also in European medicine. The
reported anti-amnestic and neuroprotective activities of both
species seem to be based on similar constituents such as
flavonoids and terpenoids which express antioxidant or more
precisely radical scavenging effects (Dinda et al., 2016; Cooper
and Ma, 2017; Huang et al., 2018). Animal experiments as well
as biochemical investigations showed that the dried fruit powder
and fruit extracts were able to increase level of physiological
antioxidants such as glutathione and antioxidative enzymes,
including superoxide dismutase or catalase, as well as to prevent
cells and tissues against free radicals in this manner (Lee et al.,
2006; Kim et al., 2011; Celep et al., 2012; Lee N. H. et al.,
2012; Sozanski et al., 2014). In particular, morroniside (8) has
been proved to protect human neuroblastoma cells against
H2O2-induced stress, inhibit the apoptosis and accumulation of
intracellular Ca2+ as well as restore the mitochondrial potential
in SH-SY5Y cell line (Wang W. et al., 2008; Wang et al.,
2009). The results of in vitro studies in cellular models were
confirmed in cerebral ischemia model in rats. Morroniside (8)
at the concentration range from 30 to 270 mg/kg body weight
significantly reduced infarct volume, alleviated neurological
impairment caused by ischemia/reperfusion-induced brain
injury as well as enhanced progenitor cell proliferation (Wang
et al., 2010; Sun et al., 2014a,b). Some special reports
indicate the improvement of neurological functions in rats
after feeding with iridoid glycosides from C. officinalis (Yao
et al., 2009). Additionally, in the experimental autoimmune
encephalomyelitis in animal models the administration of
cornel iridoid glycoside significantly attenuated the symptoms
of multiple sclerosis via an increased expression of brain-
derived neurotrophic factor (BDNF) and nerve growth factor
(NGF) as well as inhibition of JAK/STAT1 and JAK/STAT3
phosphorylation and reduction of proinflammatory mediators,
such as TNF-α, IL-1β, IFN-γ, IL-17 (Yin et al., 2014; Qu
et al., 2016). Iridoids of C. officinalis also protect glutamate-
injured hippocampal cells (Jeong et al., 2012). A treatment of
rats with a polyphenolic-rich dried fruits of C. mas resulted
in increased activity of catalase in brain tissue, while in
plasma it caused the opposite effect. On the other hand,
the increased activity of paraoxonase-1 (PON1) was observed
both in rats brain and plasma what potentiate a protective
effect of PON1 with regard to the LDL and prevention of
oxidative stress. Polyphenols and ascorbic acid of C. mas fruits
were linked with this effect. Therefore, both neuroprotective
and cardioprotective effects were assumed (Francik et al.,
2014).
On the other hand, cornuside (6) as a representative for
secoiridoid glycosides turned out to be an inhibitor of β-site
amyloid precursor protein cleaving enzyme 1 (BACE1; IC50 =
55.8µg/ml) but was a weak inhibitor of acetylocholinesterase
(IC50 > 100µg/ml) and butyrylocholinesterase (IC50 >
500µg/ml). Other polyphenolic compounds isolated from fruits
of C. officinalis such as tellimagrandin I (126), tellimagrandin
II (127) and isoterchebin (139) were significant inhibitors of
all enzymes engaged in the progression of neurodegeneration
in Alzheimer’s disease (Bhakta et al., 2017). Morroniside
(8) was found to inhibit tau hyperphosphorylation, another
Alzheimer’s disease marker, via protein phosphatase 2A
activation in human neuroblastoma SK-N-SH cells (Yang
et al., 2016). The downregulation of mRNA expression of
STIM1 and the inhibition of extracellular Ca2+ influx in PC12
cell line by an aqueous extract from fruits of C. officinalis
were proposed as the potential inducing mechanisms
of neurite generation and differentiation (Wang et al.,
2015).
Cardioprotective Activity
In close relation to neuroprotection linked with antioxidant
properties, antihyperlipidemic and cardioprotective activity of
both herbal preparations were demonstrated by in vitro as well
as in vivo experiments. As mentioned before these protective
effects seem to be based on the same chemical constituents.
In animal studies for both plant materials evidence was shown
for antihypertensive effects, decreasing blood pressure and
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reduction of circulating cholesterol concentration (Park et al.,
2009; Rafieian-Kopaei et al., 2011; Asgary et al., 2014; Sozanski
et al., 2014, 2016; Hosseinpour et al., 2017). The ethanolic extract
of C. officinalis fruits has significantly inhibited adipogenesis
(87.1%) in 3T3-L1 preadipocytes (Roh and Jung, 2012; Kang
et al., 2014). In addition, it is believed that the metabolic
diseases potentially correlate with endocrine hormones due to
considerable role of cortisol in cholesterol metabolism (Fraser
et al., 1999). One report demonstrated reduction of cortisol
concentration in plasma of hamsters after supplementation of
C. mas fruits (Lofti et al., 2014). In relation to lipid metabolism,
the ability of morroniside (8) and 7-O-galloyl-D-sedoheptulose
(120) to decrease the expression of proteins associated with lipid
homeostasis SREBP-1 and SREBP-2 (sterol regulatory element
binding proteins) in kidneys of mice (db/db) and rats has been
shown (Yokozawa et al., 2009; Park et al., 2010). The direct
cardioprotective role of cornuside present in both species has
been established. The decrease of infarct volume after myocardial
ischemia/reperfusion injury in rats treated with cornuside (6)
has been assigned to the reduction of polymorphonuclear
leukocytes infiltration, myeloperoxidase (MPO) activity and
malondialdehyde (MDA) production in myocardial tissue as well
as lower serum-levels of pro-inflammatorymediators (Jiang et al.,
2011). Furthermore, this compound dilated vascular smooth
muscles through endothelium-dependent NO/cGMP signaling
pathway (Kang et al., 2007). Unfortunately, no convincing
human studies addressing these biological activities have been
published so far. Although there is one published clinical study
of a fruit extract from C. mas demonstrating its antidiabetic
effect associated with the decreasing risk factors of cardiovascular
diseases (Soltani et al., 2015). These results revealed a trend in
another clinical trial toward amelioration of lipid profile and
vascular inflammation following addition of C. mas extracts to
the daily diet of dyslipidemic children and adolescents but these
findings need to be verified by larger scale trials (Asgary et al.,
2013). However, human studies with extracts of C. officinalis
fruits have not been published so far. Discussing these effects
with respect to the ethnopharmacological reports regarding the
traditional use of both species in the past some evidence for
beneficial effects on heart and circulation system may exist. This
concerns especially the traditional use of C. mas to treat disorders
or complaints related to aging processes like diabetes, ischemia
or cardiovascular diseases (Dinda et al., 2016; Hosseinpour-
Jaghdani et al., 2017). Due to the use of C. officinalis in TCM
as a component of complex drug mixtures (Chen et al., 2008;
Liu et al., 2013; Dai et al., 2016), a clear assignment to effects
on heart and circulation system is rather difficult. However,
in preparations of TCM used for treatment of diseases often
related to aging processes the fruits of C. officinalis are abundant
constituents (Chinese Pharmacopoeia, 2015).
Antitumor Activity
Despite the reports of antitumor activity of C. mas and
C. officinalis fruits, the data do not provide any evidence that
the fruits of both species show any real antitumor activity. All
results from the literature refer to cytotoxic activities in different
tumor cell lines (A549, MCF-7, SKOV3, PC-3, HepG2, U937) but
not to animal experiments or human studies (Chang et al., 2004;
Yousefi et al., 2015). Even though a cytotoxic effect on tumor
cells is observed, the antitumor activity is not fully addressed
and cannot be interpreted. This kind of over-interpretation of
in vitro studies occurs very often but has no pharmacological
relevance. All polyphenolic compounds, including the most
abundant constituents of dogwood fruit extracts, bind to cells
in culture leading to the induction of the biological effect.
Consequently, the cytotoxicity or inhibition of proliferation
associated with changes in signaling pathways occur. Only a
clear selectivity in cytotoxicity between tumor and non-tumor
cells corresponding with appropriate animal in vivo experiments
opens up the possibility for the statement of antitumor activity.
The reported antioxidant activity for both species (Dinda et al.,
2016; Hosseinpour-Jaghdani et al., 2017; Huang et al., 2018)
might be a hint for protective effects against tumor-inducing
free radicals but for both species only in vitro models have been
used to demonstrate such effects (Chang et al., 2004; Chu et al.,
2009; Turker et al., 2012; Yousefi et al., 2015). In particular,
the flavonoids are regarded as safe and easily obtainable. For
this reason, they are considered ideal candidates for cancer




C. MAS AND C. OFFICINALIS
General
The unique anticoagulant and ophthalmic effects of dried
fruits and extracts or anthocyanin-iridoid fractions from fruits
of C. mas were assessed in the available reports. On the
other hand, the antiosteoporotic, immunomodulatory and
insecticidal properties of C. officinalis fruits, their extracts or
constituents, such as morroniside (8), polysaccharides or 5-
hydroxymethylfurfural (163), and dimethyl malate (173) were
only found. Moreover, there is no available report on the
antihyperlipidemic activity of C. officinalis. The circumstances of
needs in the traditional eastern or western medicine requiring
scientific confirmation are a pivotal factor determining scientific
research. For this reason, these differences between C. mas
and C. officinalis might arise from the lack of dedicated
studies or even from different cultural needs resulting from the
geographical distribution of both species.
Cornus mas L.
Anticoagulant Effect
Historical reports about an anticoagulant effect of fruits from
C. mas do not exist. According to the interpretation of
diseases of the circulation system, their etiology was rather
assumed in disturbances of the digestion tract based on the
theory of the four humors. The knowledge of functions and
pathological significance of platelets or the blood coagulation
system is the result of research in the twentieth century.
For this reason, single reports about pharmacological effects
of traditionally used herbal remedies on blood coagulation
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or platelet function are rather remarkable. Thus, it is worth
to note that the dried fruit powder and hydromethanolic
extracts of the fruits of C. mas showed an anticoagulant
effect in animal experiments. In hypercholesterolemic rabbits
the cornelian cherry powder reduced the plasma fibrinogen
level after feeding over 60 days. The results indicated that
consumption of this dried plant material is likely to be
beneficial in atherosclerotic patients due to its reducing effects
on fibrinogen (Asgary et al., 2010; Rafieian-Kopaei et al., 2011).
A significant decrease in the platelet distribution width (PDW)
was found in male rats treated with 50, 200, and 400 mg/kg
body weight of a hydromethanolic extract over 3 weeks. The
changes in the platelet-related parameters suggested platelet
activity inhibition without bone marrow suppression in the
treated groups in comparison with the control groups. Regarding
to the secondary products present in the drug, it is evidence
that antioxidants reduce the platelet activity through stimulation
of prostacyclin synthesis and scavenging the synthesis-inhibiting
peroxides. Recent studies have shown that polyphenols such as
quercetin (66) and catechin (88), stop NADPH oxidase enzyme
(present in platelets). Therefore, inhibiting the production of
superoxide anion (·O−2 ) and increasing the biological power of
NO consequently regulate glycoprotein pine receptors (GPIIb-
IIIa) on platelet membrane surface, that in turn inhibits
platelets’ activation and their adherence during inflammation and
thrombosis processes. Decreasing effect of the fruit extract on
platelet activity might classify it as an alternative for antiplatelet
therapy in cardiovascular diseases (Abdollahi et al., 2014).
Unfortunately, clinical studies investigating this aspect of activity
have not been published to date. Despite some similarities in the
phytochemical composition regarding the phenolic compounds
between fruits from C. mas and C. officinalis anticoagulant effects
of C. officinalis preparations are not reported in the traditional
Chinese medicine. According to the theoretical fundamentals of
Chinese medicine the blood coagulation system did not play any
role in TCM. Nevertheless, a biochemical study also proposed
an antiplatelet activity of this drug based on malic acid (171),
citric acid (176), and succinic acid (177) identified in the fruits
of C. officinalis (Zhang Q. -A. et al., 2013).
Ophthalmic Activity
It is believed that anthocyanins as well as other antioxidants
may improve the visual functions and the visual field of
patients with normal-tension glaucoma via neuroprotective
effect, inhibition of lipid peroxidation and improvement of
vascular blood flow into the optic nerve. The progressive optic
nerve damage accompanied by morphological changes, loss of
the field of vision and even increased intraocular pressure are
the symptoms of so called glaucoma. An interesting study on
the effect of an anthocyanin-iridoid fraction derived from fruits
of C. mas on intraocular pressure was conducted in rabbits.
Intraocular pressure was decreased by 19 and 25% after 2–3 h
intraconjunctival administration of the fraction or loganic acid
(3) solution (0.7%), respectively (Szumny et al., 2015). This
activity of cornelian cherries polyphenols is likely to provide
beneficial effects on vascular flow in diabetic and hypertensive
retinopathy.
Cornus officinalis Sieb. et Zucc.
Antiosteoporotic Activity
Osteoporosis as a chronic disease is closely related with aging
processes in the elderly. Chinese herbal medicines have been used
to treat this disease for a long time and among the preparations
listed in Chinese Pharmacopoeia fruits of C. officinalis are also
included (Huang et al., 2018). Based on the modern findings in
pathogenesis and treatment of osteoporosis a variety of results
from biochemical and cell biological experiments are published
which support the idea that natural products present in the plant
preparation play a beneficial role.
Extract ofC. officinalis significantly inhibits RANKL-mediated
osteoclast differentiation in a dose-dependent manner and
RANKL-induced phosphorylation of p38 and c-JUN N-terminal
kinase. In the same way, the protein expression of c-Fos and
NFATc1 is also suppressed as well as the RANKL-induced
degradation of IκB kinase (Kim J. Y. et al., 2012). Morroniside
(8), one the main constituent of extracts from C. officinalis fruits,
has been studied on osteoarthritis in human chondrocytes. This
compound increased the levels of type II collagen, and aggrecan
as well as improved the level of proteoglycans in cartilage matrix.
In this manner, it supported the survival of chondrocytes with
articular cartilage thickness (Cheng et al., 2015). Summarizing,
the extracts of C. officinalis or individual compounds inhibit
osteoclast differentiation not only in in vitro cellular models but
also in osteoporosis animal models (Xia et al., 2014). Detailed
animal studies or clinical trials are not published.
Immunomodulatory Activity
The pivotal characteristics of immunomodulators in the
maintenance of the human well-being and health cannot be
overlooked. The sources of these medicinal remedies are part
of long traditions in different regions of the world, such
as traditional Chinese medicine, which have been developed
through empirical experience. Traditional medicine employs a
holistic approach to the prevention of disease and traditional
herbal medicines are a source of components with therapeutic
value (Tiwari et al., 2018).Many studies have been conducted also
on preparations of C. officinalis and have revealed constituents
that influence the innate immune system through the stimulation
of macrophages and lymphocytes, and modulation of the
cytokine profile, which leads to a reduction of the incidence of
infections or allergic diseases.
In addition, allergic asthma is a chronic inflammatory
disease of the airways, demonstrated by symptoms such as
wheezing, coughing, breathlessness, and airways inflammation.
Investigations in a mouse model of allergic asthma suggest that
the therapeutic effects of Corni fructus are mediated by reduced
production of Th2 cytokines (IL-5), eotaxin, and specific IgE
as well as a reduced eosinophil infiltration (Kim S. H. et al.,
2012). These findings are supported by animal experiments with
polysaccharides from crude and processed C. officinalis fruits
which have an enhanced effect on non-specific immunity, specific
humoral immunity and specific cellular immunity in immuno-
depressed mice (Du et al., 2008).
Along with the anti-inflammatory effects mentioned before,
these results provide some evidence that the fruits of C. officinalis
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show immune-protective activity. Nevertheless, the evidence by
human studies is still missing.
Insecticidal Activity
An interesting biological activity is the insecticidal effect
of 5-hydroxymethylfurfural (163) and dimethyl malate (173)
determined in a bioassay-guided fractionation of methanolic
extract from the fruits of C. officinalis against larvae of D.
melanogaster. Acute toxicity against adults of D. melanogaster
was determined showing LD50 value of 34.0 and 21.5 µg/adult
for 5-hydroxymethylfurfural (168) and dimethyl malate (173),
respectively (Miyazawa et al., 2003). Such investigations were
reported rather infrequently. Nevertheless, they are important
with respect to protect health and food quality in the past and
presently. The use of such experiences could help to develop
ecological strategies for modern food storage.
CONCLUSION
The utilization of plant resources for nutrition and medicinal use
in the past belongs to the process of civilization. The investigation
of such remarkable fruits from both species is therefore not
surprising. According to the different ideas regarding the origin
of diseases and methods for therapeutic treatment, the different
use of fruits from C. mas und C. officinalis in the West and
the East could be explained. Despite all these differences it is
rather surprising that such a level of consistency is evident.
The chemical composition of C. mas and C. officinalis seems
to be well-established. However, the availability of missing
information on some groups of compounds, such as fatty acids,
carotenoids and ascorbic acid in the fruits of C. officinalis, is
still needed. Nevertheless, fruits of both species are rich in
iridoids, anthocyanins, and flavonoids. The main difference in
phytochemicals concern tannins, which were found only in
C. officinalis andmay potentially determine the biological activity
in a significant manner. However, the role of tannins, except
for 7-O-galloyl-D-sedoheptulose, was not widely considered
in the biological activity of C. officinalis fruits. Taking into
consideration the close phylogenetic relationship of both species
the question about tannins in fruits of C. mas is open. On the
other hand, tannins do not rather occur in the iridoid-rich plant
materials but this hypothesis requires detailed elucidation in this
case. Nevertheless, the transfer of medicinal experiences from
the West to the East or vice versa cannot be excluded but is not
documented in the literature for this two species. The explanation
for this consistency seems to be rather the result of testing
and empirical observation. Analyzing the ethnopharmacological
data available under modern scientific aspects and correlating
the phytochemical composition of both species, the results
show that nearly the same ingredients are also attributed for
the same activity or presumed therapeutic use. However, some
data concerning the phytochemical composition as well as
pharmacological activity of, particularly C. officinalis, are still
missed or limited due to their availability in Chinese. Thus, only
dedicated comparative investigations of C. mas and C. officinalis
fruit preparations could really provide evidence of similarities
or differences in the field of their phytochemical composition
and biological or pharmacological properties. Last but not least
is the assignation of extracts constituents potentially responsible
for the specific activity. It means that the accordance between
ethnopharmacological use of both plant materials should be
based on the well-established chemical composition as well as
simultaneous in vitro and in vivo studies, which may facilitate
the identification of active constituents. Only these studies
could validate careful observations of the users or physicians in
the past.
AUTHOR CONTRIBUTIONS
MC carried out a literature review in the field of phytochemistry
and biological activity. MM designed the draft of the manuscript
and carried out a literature review in the field of pharmacological
activity. Both authors wrote the manuscript, revised and
approved the final version of the manuscript.
REFERENCES
Abbasi, M., Abdollahi, B., Milani, P., Mohajeri, D., and Nourdadgar, A. (2014).
Effects of hydro-methanolic extract of Cornus mas on histopathological and
biochemical parameters of rats’ liver and kidney. Bothalia J. 44, 250–259.
Abdollahi, B., Mesgari Abbasi, M., Zakeri Milani, P., Nourdadgar, A. S., Banan
Khojasteh, S. M., and Nejati, V. (2014). Hydro-methanolic extract of Cornus
mas L. and blood glucose, lipid profile and hematological parameters of male
rats. Iran. Red Crescent Med. J. 16:e17784. doi: 10.5812/ircmj.17784
Alavian, S. M., Banihabib, N., Es Haghi, M., and Panahi, F. (2014).
Protective effect of Cornus mas fruits extract on serum biomarkers
in CCl4-induced hepatotoxicity in male rats. Hepat. Mon. 14:e10330.
doi: 10.5812/hepatmon.10330
Antolak, H., Czyzowska, A., Sakac, M., Mišan, A., Duragic´, O., and
Kregiel, D. (2017). Phenolic compounds contained in little-known
wild fruits as antiadhesive agents against the beverage-spoiling
bacteria Asaia spp. Molecules 22:E1256. doi: 10.3390/molecules220
81256
APG IV (2016). An update of the Angiosperm Phylogeny Group classification for
the orders and families of flowering plants: APG IV. Bot. J. Linnean Soc. 181,
1–20. doi: 10.1111/boj.12385
Asgary, S., Kelishadi, R., Rafieian-Kopaei, M., Najafi, S., Najafi, M., and Sahebkar,
A. (2013). Investigation of the lipid-modifying and antiinflammatory effects
of Cornus mas L. supplementation on dyslipidemic children and adolescents.
Pediatr. Cardiol. 34, 1729–1735. doi: 10.1007/s00246-013-0693-5
Asgary, S., Rafieian-Kopaei, M., Adelnia, A., Kazemi, S., and Shamsi, F. (2010).
Comparing the effects of lovastatin and Cornus mas fruit on fibrinogen level in
hypercholesterolemic rabbits. ARYA Atheroscler. 6, 1–5.
Asgary, S., Rafieian-Kopaei, M., Shamsi, F., Najafi, S., and Sahebkar, A.
(2014). Biochemical and histopathological study of the anti-hyperglycemic
and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in
alloxan-induced diabetic rats. J. Complement. Integr. Med. 11, 63–69.
doi: 10.1515/jcim-2013-0022
Bajic´-Ljubicˇic´, J., Popovic´, Z., Matic´, R., and Bojovic´, S. (2018). Selected phenolic
compounds in fruits of wild growing Cornus mas L. Ind. J. Tradit. Know. 17,
91–96.
Frontiers in Pharmacology | www.frontiersin.org 22 August 2018 | Volume 9 | Article 894
Czerwin´ska and Melzig Comparison Cornus mas vs. C. officinalis
Bate-Smith, E., Ferguson, I., Hutson, K., Jensen, S., Nielsen, B., and Swain, T.
(1975). Phytochemical interrelationships in the Cornaceae. Biochem. Sys. Ecol.
3, 79–89. doi: 10.1016/0305-1978(75)90046-0
Begic-Akagic, A., Drkenda, P., Vranac, A., Orazem, P., and Hudina, M. (2013).
Influence of growing region and storage time on phenolic profile of cornelian
cherry jam and fruit. Eur. J. Hort. Sci. 78, 30–39.
Bhakta, H. K., Park, C. H., Yokozawa, T., Tanaka, T., Jung, H. A., and
Choi, J. S. (2017). Potential anti-cholinesterase and beta-site amyloid
precursor protein cleaving enzyme 1 inhibitory activities of cornuside and
gallotannins from Cornus officinalis fruits. Arch. Pharm. Res. 40, 836–853.
doi: 10.1007/s12272-017-0924-z
Bilejic´, S., Golšin, B., Cerovic´, S., and Bogdanovc´, B. (2015). Pomological
characteristics of cornelian cherry (Cornus mas L.) selections in Serbia and the
possibility of growing in intensive organic orchards. Acta Univ. Agric. Silvic.
Mendel. Brun. 63, 1101–1104. doi: 10.11118/actaun201563041101
Bilejic´, S. M., Golšin, B. R., Ninic´ Todorovic´, J., Cerovic´, S. B., and Popovic´, B. M.
(2011). Physicochemical fruit characteristics of cornelian cherry (Cornus mas
L.) genotypes from Serbia. Hort. Sci. 46, 849–853.
Bozdogan, A. (2017). Viscosity and physicochemical properties of cornlian
cherry (Cornus mas L.) concentrate. Food Measure. 11, 1326–1332.
doi: 10.1007/s11694-017-9510-9
Brindza, P. (2007). Slovakian cornelian cherry (Cornus mas L.) potential for
cultivation. Acta Hort. 760, 433–438. doi: 10.17660/ActaHortic.2007.760.59
Brindza, P. (2009). Biological and commercial characteristics of cornelian cherry
(Cornus mas L.) population in the Gemer region og Slovakia. Acta Hort. 818,
85–94. doi: 10.17660/ActaHortic.2009.818.11
Cai, H., Cao, G., and Cai, B. (2013). Rapid simultaneous identification and
determination of the multiple compounds in crude Fructus Corni and its
processed products by HPLC-MS/MSwithmultiple reactionmonitoring mode.
Pharm. Biol. 51, 273–278. doi: 10.3109/13880209.2012.720689
Cao, G., Zhang, C., Zhang, Y., Cong, X., Cai, H., and Cai, B. (2012). Screening
and identification of potential active components in crude Fructus Corni using
solid-phase extraction and LC-LTQ-linear ion trap mass spectrometry. Pharm.
Biol. 50, 278–283. doi: 10.3109/13880209.2011.599036
Cao, G., Zhang, Y., Feng, J., Cai, H., Zhang, C., Ding, M., et al. (2011).
A rapid and sensitive assay for determining the main components in
processed Fructus Corni by UPLC-Q-TOF-MS. Chromatographia 73, 135–141.
doi: 10.1007/s10337-010-1825-1
Capanoglu, E., Boyacioglu, D., De Vos, R. C. H., Hall, R., and Beekwilder, J.
(2011). Procyanidins in fruit from Sour cherry (Prunus cerasus) differ strongly
in chainlength from those in Laurel cherry (Prunus lauracerasus) and Cornelian
cherry (Cornus mas). J. Berry Res. 1, 137–146. doi: 10.3233/BR-2011-015
Celep, E., Aydin, A., and Yesilada, E. (2012). A comparative study on the
in vitro antioxidant potentials of three edible fruits: cornelian cherry,
Japanese persimmon and cherry laurel. Food Chem. Toxicol. 50, 3329–3335.
doi: 10.1016/j.fct.2012.06.010
Chang, J., Chiang, L., Hsu, F., and Lin, C. (2004). Chemoprevention against
hepatocellular carcinoma of Cornus officinalis in vitro. Am. J. Chin. Med. 32,
717–725. doi: 10.1142/S0192415X04002296
Chen, C. C., Hsu, C. Y., Chen, C. Y., and Liu, H. K. (2008). Fructus Corni
suppresses hepatic gluconeogenesis related gene transcription, enhances
glucose responsiveness of pancreatic beta-cells, and prevents toxin induced
beta-cell death. J. Ethnopharmacol. 117, 483–490. doi: 10.1016/j.jep.2008.0
2.032
Cheng, L., Zeng, G., Liu, Z., Zhang, B., Cui, X., Zhao, H., et al. (2015).
Protein kinase B and extracellular signal-regulated kinase contribute to the
chondroprotective effect of morroniside on osteoarthritis chondrocytes. J. Cell.
Mol. Med. 19, 1877–1886. doi: 10.1111/jcmm.12559
Chinese Pharmacopoeia (2015). Pharmacopoeia of the People’s Republic of China.
Beijing: People’s Medical Publishing House.
Choi, Y. H., Jin, G. Y., Li, G. Z., and Yan, G. H. (2011). Cornuside suppresses
lipopolysaccharide-induced inflammatory mediators by inhibiting nuclear
factor-kappa B activation in RAW 264.7 macrophages. Biol. Pharm. Bull. 34,
959–966. doi: 10.1248/bpb.34.959
Chu, Q., Satoh, K., Kanamoto, T., Terakubo, S., Nakashima, H., Wang, Q.,
et al. (2009). Antitumor potential of three herbal extracts against human oral
squamous cell lines. Anticancer Res. 29, 3211–3219.
Cooper, E. L., and Ma, M. J. (2017). Alzheimer disease: clues from traditional
and complementary medicine. J. Tradit. Complement. Med. 7, 380–385.
doi: 10.1016/j.jtcme.2016.12.003
Çopur, U., Soylu, A., Gürbüz, N., Degirmencioglu, N., and Ertürk, Ü. (2003).
Suitability of Cornus mas (cornelian cherry) genotypes and cultivars for fruit
juice. Biotechnol. Biotechnol. Eq. 17, 176–182. doi: 10.1080/13102818.2003.108
19217
Cosmulescu, S., Trandafir, I., and Nour, V. (2017). Phenolic acids and flavonoids
profiles of extracts from edible wild fruits and their antioxidant properties. Int.
J. Food Prop. 20, 3124–3134. doi: 10.1080/10942912.2016.1274906
Czyzowska, A., Kucharska, A. Z., Nowak, A., Sokół-Łetowska, A., Motyl, I., and
Piórecki, N. (2017). Suitability of the probiotic lactic acid bacteria strains as
the starter cultures in unripe cornelian cherry (Cornus mas L.) fermentation. J.
Food Sci. Technol. 54, 2936–2946. doi: 10.1007/s13197-017-2732-3
Dai, B., Wu, Q., Zeng, C., Zhang, J., Cao, L., Xiao, Z., et al. (2016). The effect of
Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2
diabetes mellitus (T2DM) rats with insulin resistance. J. Ethnopharmacol. 192,
382–389. doi: 10.1016/j.jep.2016.07.024
Demir, F., and Kalyoncu, I. H. (2003). Some nutritional, pomological and physical
properties of cornelian cherry (Cornus mas L.). J. Food Eng. 60, 335–341.
doi: 10.1016/S0260-8774(03)00056-6
Deng, S., West, B. J., and Jensen, C. J. (2013). UPLC-TOF-MS characterization and
identification of bioactive iridoids in Cornus mas fruit. J. Anal. Methods Chem.
2013:710972. doi: 10.1155/2013/710972
Desai, S. J., Prickril, B., and Rasooly, A. (2018). Mechanisms of phytonutrient
modulation of cyclooxygenase-2 (COX-2) and inflammation related
to cancer. Nutr. Cancer 70, 350–375. doi: 10.1080/01635581.2018.14
46091
Dinda, B., Kyriakopoulos, A. M., Dinda, S., Zoumpourlis, V., Thomaidis,
N. S., Velegraki, A., et al. (2016). Cornus mas L. (cornelian cherry), an
important European and Asian traditional food and medicine: ethnomedicine,
phytochemistry and pharmacology for its commercial utilization in drug
industry. J. Ethnopharmacol. 193, 670–690. doi: 10.1016/j.jep.2016.09.042
Dokoupil, L., and Reznícˇek, V. (2012). Production and use of the cornelian
cherry–Cornus mas L. Acta Univ. Agric. Silvic. Mendel. Brun. 60, 49–58.
doi: 10.11118/actaun201260080049
Dragendorff, G. (1898). Die Heilpflanzen der verschiedenen Völker und Zeiten.
Stuttgart: Ferdinand Enke Verlag.
Dragovic´-Uzelac, V., Levaj, B., Bursac´, D., Pedisic´, S., Radojcˇic´, I., and Biško, A.
(2007). Total phenolics and antioxidant capacity assays of selected fruits. Agric.
Conspec. Sci. 72, 279–284.
Drkenda, P., Spahic, A., Begic-Akagic, A., Gasi, F., Vranac, A., Hudina, M.,
et al. (2014). Pomological characteristics of some autochthnous genotypes of
cornelian cherry (Cornus mas L.) in Bosnia and Herzegovina. Erwerbs-Obstbau
56, 59–66. doi: 10.1007/s10341-014-0203-9
Du, C.-T., and Francis, F. J. (1973). Anthocyanins from Cornus mas.
Phytochemistry 12, 2487–2489. doi: 10.1016/0031-9422(73)80460-1
Du, W., Cai, H., Wang, M., Ding, X., Yang, H., and Cai, B. (2008). Simultaneous
determination of six active components in crude and processed Fructus Corni
by high performance liquid chromatography. J. Pharm. Biomed. Anal. 48,
194–197. doi: 10.1016/j.jpba.2008.04.021
Ersoy, N., Bagci, Y., and Gok, V. (2011). Antioxidant properties of 12 cornelian
cherry fruit types (Cornus mas L.) slected from Turkey. Sci. Res. Essays 6,
98–102. doi: 10.5897/SRE10.740
Es Haghi, M., Dehghan, G., Banihabib, N., Zare, S., Mikaili, P., and Panahi,
F. (2014). Protective effects of Cornus mas fruit extract on carbon
tetrachloride induced nephrotoxicity in rats. Ind. J. Nephrol. 24, 291–296.
doi: 10.4103/0971-4065.133000
Eyde, R. (1988). Comprehending Cornus: puzzles and progress in the systematics
of the dogwoods. Bot. Rev. (Lancaster) 54, 233–351. doi: 10.1007/BF028
68985
Fan, C., and Xiang, Q.-Y. (2001). Phylogenetic relationships within Cornus
(Cornaceae) based on 26S rDNA sequences. Am. J. Bot. 88, 1131–1138.
doi: 10.2307/2657096
Forman, V., Haladová, M., Grancˇai, D., and Ficková, M. (2015). Antiproliferative
activities of water infusions from leaves of five Cornus L. species.Molecules 20,
22546–22552. doi: 10.3390/molecules201219786
Frontiers in Pharmacology | www.frontiersin.org 23 August 2018 | Volume 9 | Article 894
Czerwin´ska and Melzig Comparison Cornus mas vs. C. officinalis
Fournier, P. (ed.). (1948). Le Livre des Plantes Médicinales et Vénéneuses de France.
Paris: Paul Lechevalier.
Francik, R., Kros´niak, J., Krosniak, M., Berköz, M., Sanocka, I., and Francik, S.
(2014). The neuroprotective effect of Cornus mas on brain tissue of Wistar rats.
Sci. World J. 2014:847368. doi: 10.1155/2014/847368
Fraser, R., Ingram, M. C., Anderson, N. H., Morrison, C., Davies, E., and
Connell, J. M. (1999). Cortisol effects on body mass, blood pressure,
and cholesterol in the general population. Hypertension 33, 1364–1368.
doi: 10.1161/01.HYP.33.6.1364
Gao, D., Li, N., Li, Q., Li, J., Han, Z., Fan, Y., et al. (2008). Study of the extraction,
purification and antidiabetic potential of ursolic acid from Cornus officinalis
Sieb. et Zucc. Therapy 5, 697–705. doi: 10.2217/14750708.5.5.697
Gao, D., Li, Q., Gao, Z., and Wang, L. (2012). Antidiabetic effects of Corni Fructus
extract in streptozotocin-induced diabetic rats. Yonsei Med. J. 53, 691–700.
doi: 10.3349/ymj.2012.53.4.691
Gastoł, M., Kros´niak, M., Derwisz, M., and Dobrowolska-Iwanek, J. (2013).
Cornelian cherry (Cornus mas L.) juice as a potential source of biological
compounds. J. Med. Food 16, 728–732. doi: 10.1089/jmf.2012.0248
Gibson, G. (2008). Prebiotics as gut microflora management tools. J. Clin.
Gastroenterol. 42, S75–79. doi: 10.1097/MCG.0b013e31815ed097
Grune, T., Lietz, G., Palou, A., Ross, A., Stahl,W., Tang, G., et al. (2010). β-Carotene
is an important vitamin A source for humans. J. Nutr. 140, 2268S−2285S.
doi: 10.3945/jn.109.119024
Güleryüz, M., Bolat, I., and Pirlak, L. (1998). Selection of table cornelian cherry
(Cornus mas L.) types of Çoruh Valley. Turk. J. Agric. For. 22, 357–364.
Gunduz, K., Saracoglu, O., Özgen, M., and Serce, S. (2013). Antioxidant, physical
and chemical characteristics of cornelian cherry fruits (Cornus mas L.) at
different stages of ripeness. Acta Sci. Pol. Hortorum Cultus 12, 59–66.
Hamid, H., Yousef, H., Jafar, H., and Mohammad, A. (2011). Antioxidant capacity
and phytochemical properties of cornelian cherry (Cornus mas L.) genotypes in
Iran. Sci. Hortic. 129, 459–463. doi: 10.1016/j.scienta.2011.04.017
Han, Y., Jung, H. W., and Park, Y. K. (2014). Selective therapeutic effect of Cornus
officinalis fruits on the damage of different organs in STZ-induced diabetic rats.
Am. J. Chin. Med. 42, 1169–1182. doi: 10.1142/S0192415X14500736
Hassanpour, H., Hamidoghli, Y., and Samizadeh, H. (2012). Some fruit
characeteristics of Iranian cornelian cherries (Cornus mas L.). Not. Bot. Horti.
Agrobo 40, 247–252. doi: 10.15835/nbha4017385
Hatano, T., Ogawa, N., Kira, R., Yasuhara, T., and Okuda, T. (1989a). Tannins of
Cornaceous plants. I. Cornusiins A, B and C, dimeric monomeric and trimeric
hydrolyzable tannins from Cornus officinalis, and orientation of valoneoyl
group in related tannins. Chem. Pharm. Bull. (Tokyo) 37, 2083–2090.
Hatano, T., Yasuhara, T., Abe, R., and Okuda, T. (1990). A galloylated
monoterpene glucoside and a dimeric hydrolysable tannin from Cornus
officinalis. Phytochemistry 29, 2975–2978. doi: 10.1016/0031-9422(90)87118-E
Hatano, T., Yasuhara, T., and Okuda, T. (1989b). Tannins of Cornaceous plants.
II. Cornusiins D, E and F, new dimeric and trimeric hydrolyzable tannins from
Cornus officinalis. Chem. Pharm. Bull. (Tokyo) 37, 2665–2669.
He, J., Ye, X. S., Wang, X. X., Yang, Y. N., Zhang, P. C., Ma, B. Z., et al. (2017).
Four new iridoid glucosides containing the furan ring from the fruit of Cornus
officinalis. Fitoterapia 120, 136–141. doi: 10.1016/j.fitote.2017.06.003
He, K., Song, S., Zou, Z., Feng, M., Wang, D., Wang, Y., et al. (2016). The
hypoglycemic and synergistic effect of loganin, morroniside, and ursolic acid
isolated from the fruits of Cornus officinalis. Phytother. Res. 30, 283–291.
doi: 10.1002/ptr.5529
Horváth, G., Turcsi, E., Molnár, P., Szabó, L. G., and Deli, J. (2007). “Isolation and
identification of carotenoids in the fruit of cornelian cherry (Cornus mas L.),”
in 55th International Congress and Annual Meeting of the Society for Medicinal
Plant Research. ed P. Medica (Graz, Austria: Thieme Publisher).
Hosseinpour, F., Shomali, T., and Rafieian-Kopaei, M. (2017).
Hypocholesterolemic activity of cornelian cherry (Cornus mas L.) fruits. J.
Complement. Integr. Med. 14:20170007. doi: 10.1515/jcim-2017-0007
Hosseinpour-Jaghdani, F., Shomali, T., Gholipour-Shahraki, A., Rahimi-Madiseh,
M., and Rafieian-Kopaei, M. (2017). Cornus mas: a review on traditional uses
and pharmacological properties. J. Complement. Integr. Med. 14:20160137.
doi: 10.1515/jcim-2016-0137
Hosu, A., Cimpoiu, C., David, L., and Moldovan, B. (2016). Study of the
antioxidant property variation of cornelian cherry fruits during storage using
HPTLC and spectrophotometric assays. J. Anal. Methods Chem. 2016:2345375.
doi: 10.1155/2016/2345375
Huang, J., Zhang, Y., Dong, L., Gao, Q., Yin, L., Quan, H., et al. (2018).
Ethnopharmacology, phytochemistry, and pharmacology of Cornus officinalis
Sieb. et Zucc. J. Ethnopharmacol. 213, 280–301. doi: 10.1016/j.jep.2017.11.010
Hwang, K. A., Hwang, Y. J., and Song, J. (2016). Antioxidant activities
and oxidative stress inhibitory effects of ethanol extracts from Cornus
officinalis on raw 264.7 cells. BMC Complement. Altern. Med. 16:196.
doi: 10.1186/s12906-016-1172-3
Inouye, H., Shinichi, U., Inoue, K., and Takeda, Y. (1974). Studies on monoterpene
glucosides and related natural products. XXIII. Biosynthesis of the secoiridoid
glucosides, gentiopicroside, morroniside, oleuropein, and jasminin. Chem.
Pharm. Bull. 22, 676–686. doi: 10.1248/cpb.22.676
Jac´imovic´, V., BoŽovic´, D., Ercisli, S., Ognjanov, V., and Bosancˇic´, B. (2015).
Some fruit characteristics of selected cornelian cherries (Cornus mas L.) from
Montenegro. Erwerbs-Obstbau 57, 119–124. doi: 10.1007/s10341-015-0238-6
Jang, S. E., Jeong, J. J., Hyam, S. R., Han, M. J., and Kim, D. H. (2014). Ursolic
acid isolated from the seed of Cornus officinalis ameliorates colitis in mice
by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on
macrophages. J. Agric. Food Chem. 62, 9711–9721. doi: 10.1021/jf501487v
Jayaprakasam, B., Olson, L. K., Schutzki, R. E., Tai, M. H., and Nair, M. G. (2006).
Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice
by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J. Agric.
Food Chem. 54, 243–248. doi: 10.1021/jf0520342
Jayaprakasam, B., Vareed, S. K., Olson, L. K., and Nair, M. G. (2005). Insulin
secretion by bioactive anthocyanins and anthocyanidins present in fruits. J.
Agric. Food Chem. 53, 28–31. doi: 10.1021/jf049018+
Jensen, S., Kjaer, A., and Nielsen, B. (1975). The genus Cornus: non-
flabonoid glucosides as taxonomic markers. Biochem. Sys. Ecol. 3, 75–78.
doi: 10.1016/0305-1978(75)90045-9
Jensen, S. R., Kjaer, A., and Nielsen, B. J. (1973). Loniceroside (secologanin)
in Cornus officinalis and C. mas. Phytochemistry 12, 2064–2065.
doi: 10.1016/S0031-9422(00)91544-9
Jeong, E. J., Kim, T. B., Yang, H., Kang, S. Y., Kim, S. Y., Sung, S. H., et al.
(2012). Neuroprotective iridoid glycosides from Cornus officinalis fruits against
glutamate-induced toxicity in HT22 hippocampal cells. Phytomedicine 19,
317–321. doi: 10.1016/j.phymed.2011.08.068
Ji, W., Wang, T., Liu, W., Liu, F., Guo, L., Geng, Y., et al. (2017). Water-
compatible micron-sized monodisperse molecularly imprinted beads
for selective extraction of five iridoid glycosides from Cornus officinalis
fructus. J. Chromatogr. A 1504, 1–8. doi: 10.1016/j.chroma.2017.0
5.003
Jiang, W. L., Chen, X. G., Zhu, H. B., and Tian, J. W. (2009). Effect of cornuside on
experimental sepsis. Planta Med. 75, 614–619. doi: 10.1055/s-0029-1185383
Jiang, W. L., Zhang, S. M., Tang, X. X., and Liu, H. Z. (2011). Protective roles
of cornuside in acute myocardial ischemia and reperfusion injury in rats.
Phytomedicine 18, 266–271. doi: 10.1016/j.phymed.2010.07.009
Jiang, W. L., Zhang, S. P., Hou, J., and Zhu, H. B. (2012). Effect of
loganin on experimental diabetic nephropathy. Phytomedicine 19, 217–222.
doi: 10.1016/j.phymed.2011.08.064
Jiang, Y., Chen, H., Wang, L., Zou, J., Zheng, X., and Liu, Z. (2016). Quality
evaluation of polar and active components in crude and processed Fructus
Corni by quantitative analysis of multicomponents with single marker. J. Anal.
Methods Chem. 2016:6496840. doi: 10.1155/2016/6496840
Kalyoncu, I. H., Ersoy, N., and Yilmaz, M. (2009). Physico-chemical and
nutritional properties of cornelian cherry fruits (Cornus mas L.) grown in
Turkey. Asian J. Chem. 21, 6555–6561.
Kang, C., Kwon, Y., and So, J. (2014). Anti-adipogenic effects of Corni
fructus in 3T3-L1 preadipocytes. Biotechnol. Bioprocess Eng. 19, 52–57.
doi: 10.1007/s12257-013-0444-8
Kang, D. G., Choi, D. H., Lee, J. K., Lee, Y. J., Moon, M. K., Yang, S. N., et al.
(2007). Endothelial NO/cGMP-dependent vascular relaxation of cornuside
isolated from the fruit of Cornus officinalis. Planta Med. 73, 1436–1440.
doi: 10.1055/s-2007-990243
Karadeniz, T., Deligöz, M. S., Çorumlu, M., Senyurt, M., and Bak, T. (2009).
Selection of native cornelian cherries grown in Çorum (Turkey). Acta Hort.
825, 83–88. doi: 10.17660/ActaHortic.2009.825.9
Frontiers in Pharmacology | www.frontiersin.org 24 August 2018 | Volume 9 | Article 894
Czerwin´ska and Melzig Comparison Cornus mas vs. C. officinalis
Kim, D. K., and Kwak, J. H. (1998). A furan derivative from Cornus officinalis.
Arch. Pharm. Res. 21, 787–789. doi: 10.1007/BF02976779
Kim, H. J., Kim, B. H., and Kim, Y. C. (2011). Antioxidative action of corni
fructus aqueous extract on kidneys of diabetic mice. Toxicol. Res. 27, 37–41.
doi: 10.5487/TR.2011.27.1.037
Kim, J. Y., Kim, Y. K., Choi, M. K., Oh, J., Kwak, H. B., and Kim, J. J. (2012).
Effect of Cornus officinalis on receptor activator of nuclear factor-kappaB
ligand (RANKL)-induced osteoclast differentiation. J. BoneMetab. 19, 121–127.
doi: 10.11005/jbm.2012.19.2.121
Kim, S. H., Kim, B. K., and Lee, Y. C. (2012). Effects of Corni fructus on ovalbumin-
induced airway inflammation and airway hyper-responsiveness in a mouse
model of allergic asthma. J. Inflamm. (Lond). 9:9. doi: 10.1186/1476-9255-9-9
Kostecka, M., Szot, I., Czernecki, T., and Szot, P. (2017). Vitamin C content of new
ecotypes of cornelian cherry (Cornus mas L.) determined by various analytical
methods. Acta Sci. Hortorum Cultus 16, 53–61. doi: 10.24326/asphc.2017.4.6
Krivoruchko, E. V. (2014). Carboxylic acids from Cornus mas. Chem. Nat. Comp.
50:112. doi: 10.1007/s10600-014-0879-y
Krzys´ciak, P., Kos´niak, M., Gastoł, M., Ochonska, D., and Krzys´ciak, W. (2011).
Antimicrobial activity of Cornelian cherry (Cornus mas L.). Post Fitoter. 4,
227–231.
Kucharska, A. Z. (2012). Zwiazki aktywne Owoców Derenia (Cornus mas L.).
Wrocław: Wrocław University of Environmental and Life Sciences.
Kucharska, A. Z., Szumny, A., Sokół-Łetowska, A., Piórecki, N., and Klymenko,
S. V. (2015). Iridoids and anthocyanins in cornelian cherry (Cornus mas L.)
cultivars. J. Food Comp. Anal. 40, 95–102. doi: 10.1016/j.jfca.2014.12.016
Kyriakopoulos, A. M., and Dinda, B. (2015). Cornus mas (Linnaeus) novel
devised medicinal preparations: bactericidal effect against Staphylococcus
aureus and Pseudomonas aeruginosa. Molecules 20, 11202–11218.
doi: 10.3390/molecules200611202
Lee, A. Y., Kim, H. S., Jo, J. E., Kang, B. K., Moon, B. C., Chun, J. M., et al.
(2012). Optimization of extraction condition for major iridoid components
in fruit of corni (Cornus officinalis) by UPLC-PDA using response surface
methodology. Food Sci. Biotechnol. 21, 1023–1029. doi: 10.1007/s10068-012-0
133-y
Lee, J., Jang, D. S., Kim, N. H., Lee, Y. M., Kim, J., and Kim, J. S. (2011). Galloyl
glucoses from the seeds of Cornus officinalis with inhibitory activity against
protein glycation, aldose reductase, and cataractogenesis ex vivo. Biol. Pharm.
Bull. 34, 443–446. doi: 10.1248/bpb.34.443
Lee, N. H., Seo, C. S., Lee, H. Y., Jung, D. Y., Lee, J. K., Lee, J. A.,
et al. (2012). Hepatoprotective and antioxidative activities of Cornus
officinalis against acetaminophen-induced hepatotoxicity in mice. Evid.
Based Complement. Alternat. Med. 2012:804924. doi: 10.1155/2012/
804924
Lee, S. H., Tanaka, T., Nonaka, G.-I., and Nishioka, I. (1989). Sedoheptulose
digallate from Cornus officinalis. Phytochemistry 28, 3469–3472.
doi: 10.1016/0031-9422(89)80366-8
Lee, S. O., Kim, S. Y., Han, S. M., Kim, H. M., Ham, S. S., and Kang, I. J. (2006).
Corni fructuc scavenges hydroxy radicals and decreases oxidative stress in
endothelial cells. J. Med. Food 9, 594–598. doi: 10.1089/jmf.2006.9.594
Li, P., Yan, Y. B., Yu, L. Z., andMa, R. Y. (2012). Characterization and anti-oxidant
activities of polysascharides from Fructus Corni. Adv. Mat. Res. 560, 231–236.
doi: 10.4028/www.scientific.net/AMR.560-561.231
Lin, M. H., Liu, H. K., Huang,W. J., Huang, C. C., Wu, T. H., and Hsu, F. L. (2011).
Evaluation of the potential hypoglycemic and Beta-cell protective constituents
isolated from Corni fructus to tackle insulin-dependent diabetes mellitus. J.
Agric. Food. Chem. 59, 7743–7751. doi: 10.1021/jf201189r
Liu, H., Xu, H., Shen, C., and Wu, C. (2012). Effect of the best compatibility of
components in Corni Fructus on WT1 expression in glomerular podocytes of
type 2 diabetic rats with early nephropathy. Am. J. Chin. Med. 40, 537–549.
doi: 10.1142/S0192415X12500413
Liu, J. P., Feng, L., Zhang, M. H., Ma, D. Y., Wang, S. Y., Gu, J., et al.
(2013). Neuroprotective effect of Liuwei Dihuang decoction on cognition
deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat. J.
Ethnopharmacol. 150, 371–381. doi: 10.1016/j.jep.2013.09.003
Liu, X., Han, Z. P., Wang, Y. L., Gao, Y., and Zhang, Z. Q. (2011).
Analysis of the interactions of multicomponents in Cornus officinalis Sieb.
et Zucc. with human serum albumin using on-line dialysis coupled with
HPLC. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879, 599–604.
doi: 10.1016/j.jchromb.2011.01.022
Liu, Z., Zhu, Z. Y., Zhang, H., Tan, G. G., Chen, X. F., and Chai, Y. F. (2011).
Qualitative and quantitative analysis of Fructus Corni using ultrasound assisted
microwave extraction and high performance liquid chromatography coupled
with diode array UV detection and time-of-flight mass spectrometry. J. Pharm.
Biomed. Anal. 55, 557–562. doi: 10.1016/j.jpba.2011.02.007
Lofti, A., Shahryar, A., and Rasoolian, H. (2014). Effects of cornelian cherry
(Cornus mas L.) fruit on plasma lipids, cortisol, T3 and T4 levels in hamsters. J.
Anim. Plant Sci. 24, 459–462.
Lv, G., Lv, X., Tao, Y., and Xu, H. (2016). Effect of morroniside on glomerular
mesangial cells through AGE-RAGE pathway. Hum. Cell 29, 148–154.
doi: 10.1007/s13577-015-0128-0
Ma, Q., Liu, X., Franks, R. G., and Xiang, Q.-Y. (2017). Alterations of CorTFL1
andCorAP1 expression correlate withmajor evolutionary shifts of inflorescence
architecture in Cornus (Cornaceae) - a proposed model for variation of closed
inflorescence forms. New Phytol. 216, 519–535. doi: 10.1111/nph.14197
Ma, W., Wang, K. J., Cheng, C. S., Yan, G. Q., Lu, W. L., Ge, J. F., et al. (2014).
Bioactive compounds from Cornus officinalis fruits and their effects on diabetic
nephropathy. J. Ethnopharmacol. 153, 840–845. doi: 10.1016/j.jep.2014.03.051
Mau, J., Chen, C., and Hsieh, P. (2001). Antimicrobial effect of extracts from
Chinese chive, cinnamon, and corni fructus. J. Agric. Food Chem. 49, 183–188.
doi: 10.1021/jf000263c
Milenkovic´-Andjelkovic´, A. S., Andjelkovic´, M. Z., Radovanovic´, A. N.,
Radovanovic´, B. C., and Nikolic´, V. (2015). Phenol composition, DPPH radical
scavenging and antimicrobial activity of Cornelian cherry (Cornus mas) fruit
and leaf extracts. Hem. Ind. 69, 331–337. doi: 10.2298/HEMIND140216046M
Mirbadalzadeh, R., and Shirdel, Z. (2012). Antihyperglycemic and
antihyperlipidemic effects of Cornus mas extract in diabetic rats compared
with glibenclamide. Elixir Hormo. Signal. 47, 8969–8972.
Miyazawa,M., Anzai, J., Fujioka, J., and Isikawa, Y. (2003). Insecticidal compounds
againstDrosophilamelanogaster fromCornus officinalis Sieb. et Zucc.Nat. Prod.
Res. 17, 337–339. doi: 10.1080/1057563031000072587
Moldovan, B., Filip, A., Clichici, S., Suharoschi, R., Bolfa, P., and David, L. (2016).
Antioxidant activity of Cornelian cherry (Cornus mas L.) fruits extract and the
in vivo evaluation of its anti-inflammatory effects. J. Funct. Foods 26, 77–87.
doi: 10.1016/j.jff.2016.07.004
Narimani-Rad, M., Zendehdel, M., Abbasi, M., Abdollahi, B., and Lotfi, A. (2013).
Cornelian cherry (Cornus mas L.) extract affects glycemic status in Wistar rats.
Bull. Env. Pharmacol. Life Sci. 2, 48–50.
Nawirska-Olszanska, A., Kucharska, A., and Sokół-Łetowska, A. (2010). Dietary
fibre fractions in cornelian cherry fruit (Cornus mas L.). Z˙ywnos´c´: nauka-
technologia-jakos´c´ 2, 95–103.
Nouska, C., Kazakos, S., Mantzourani, I., Alexopoulos, A., Bezirtzoglou, E.,
and Plessas, S. (2016). Fermentation of Cornus mas L. juice for functional
low alcoholic beverage production. Curr. Res. Nutr. Food Sci. 4, 119–124.
doi: 10.12944/CRNFSJ.4.Special-Issue-October.16
Okuda, T., Hatano, T., and Ogawa, N. (1984). Cornusiin A, a dimeric ellagitannin
forming four tautomers, and accompanying new tannins in Cornus officinalis.
Chem. Pharm. Bull. 32, 4662–4665. doi: 10.1248/cpb.32.4662
Okuda, T., Hatano, T., and Yasui, T. (1981). Revised structure of
isoterchebin, isolated from Cornus officinalis. Heterocycles 16, 1321–1324.
doi: 10.3987/R-1981-08-1321
Pantelidis, G. E., Vasilakakis, M., Manganaris, G. A., and Diamantidis, G.
(2007). Antioxidant capacity, phenol, anthcyanin and ascorbic acid contents
in raspberries, blackberries, red currants, gooseberries and Cornelian cherries.
Food Chem. 102, 777–783. doi: 10.1016/j.foodchem.2006.06.021
Park, C., Tanaka, T., and Yokozawa, T. (2013). Anti-diabetic action of 7-O-galloyl-
D-sedoheptulose, a polyphenol from Corni Fructus, through ameliorating
inflammation and inflammation-related oxidative stress in the pancreas of type
2 diabetics. Biol. Pharm. Bull. 36, 723–732. doi: 10.1248/bpb.b12-00543
Park, C. H., Cho, E. J., and Yokozawa, T. (2009). Protection against
hypercholesterolemia by Corni fructus extract and its related protective
mechanism. J. Med. Food 12, 973–981. doi: 10.1089/jmf.2009.0037
Park, C. H., Noh, J. S., Tanaka, T., Roh, S. S., Lee, J. C., and Yokozawa, T.
(2015). Polyphenol isolated from Corni Fructus, 7-O-galloyl-D-sedoheptulose,
modulates advanced glycation endproduct-related pathway in type 2 diabetic
Frontiers in Pharmacology | www.frontiersin.org 25 August 2018 | Volume 9 | Article 894
Czerwin´ska and Melzig Comparison Cornus mas vs. C. officinalis
db/db mice. Arch. Pharm. Res. 38, 1270–1280. doi: 10.1007/s12272-014-0
457-7
Park, C. H., Noh, J. S., Tanaka, T., Uebaba, K., Cho, E. J., and Yokozawa, T. (2011).
The effects of corni fructus extract and its fractions against alpha-glucosidase
inhibitory activities in vitro and sucrose tolerance in normal rats. Am. J. Chin.
Med. 39, 367–380. doi: 10.1142/S0192415X11008889
Park, C. H., Noh, J. S., Tanaka, T., and Yokozawa, T. (2010). Effects of
morroniside isolated from Corni Fructus on renal lipids and inflammation in
type 2 diabetic mice. J. Pharm. Pharmacol. 62, 374–380. doi: 10.1211/jpp.62.
03.0013
Park, C. H., Noh, J. S., Tanaka, T., and Yokozawa, T. (2012a). 7-O-galloyl-D-
sedoheptulose ameliorates renal damage triggered by reactive oxygen species-
sensitive pathway of inflammation and apoptosis. J. Pharm. Pharmacol. 64,
1730–1740. doi: 10.1111/j.2042-7158.2012.01559.x
Park, C. H., Tanaka, T., Kim, H. Y., Park, J. C., and Yokozawa, T. (2012b).
Protective effects of Corni Fructus against advanced glycation endproducts
and radical scavenging. Evid. Based Complement. Alternat. Med. 2012:418953.
doi: 10.1155/2012/418953
Park, J. Y., Han, A. R., Kil, Y. S., Kang, U., Kim, S. H., Nam, S. J., et al. (2016). A
new secoiridoid glycoside from the fruits of Cornus officinalis (Cornaceae).Nat.
Prod. Res. 30, 1504–1510. doi: 10.1080/14786419.2015.1115996
Pawlowska, A. M., Camangi, F., and Braca, A. (2010). Quali-quantitative analysis
of flavonoids of Cornus mas L. (Cornaceae) fruits. Food Chem. 119, 1257–1261.
doi: 10.1016/j.foodchem.2009.07.063
Perova, I. B., Zhogova, A. A., Poliakova, A. V., Éller, K. I., Ramenskaia, G. V., and
Samylina, I.A. (2014). Biologically active substances of cornelian cherry fruits
(Cornus mas L.). Vopr. Pitan. 83, 86–94.
Popovic´, B. M., Štajner, D., Slavko, K., and Sandra, B. (2012). Antioxidant capacity
of cornelian cherry (Cornus mas L.)–comparison between permanganate
reducing antioxidant capacity and other antioxidant methods. Food Chem. 134,
734–741. doi: 10.1016/j.foodchem.2012.02.170
Popovic´, Z., Matic´, R., Bajic´-Ljubicˇic´, J., Teševic´, V., and Bojovic´, S. (2017).
Geographical variability of selected phenolic compounds in fresh berries of two
Cornus species. Trees. 32, 203–214. doi: 10.1007/s00468-017-1624-5
Pyrkosz-Biardzka, K., Kucharska, A., Sokol-Łetowska, A., Strugała, P.,
and Gabrielska, J. (2014). A comprehensive study on antioxidant
properties of crude extracts from fruits of Berberis vulgaris L., Cornus
mas L. and Mahonia aquifolium Nutt. Pol. J. Food Nutr. Sci. 64, 91–99.
doi: 10.2478/v10222-012-0097-x
Qu, Z., Zheng, N., Zhang, Y., Zhang, L., Liu, J., Wang, Q., et al. (2016). Preventing
the BDNF and NGF loss involved in the effects of cornel iridoid glycoside on
attenuation of experimental autoimmune encephalomyelitis in mice. Neurol.
Res. 38, 831–837. doi: 10.1080/01616412.2016.1200766
Rad, Z. S., Pakbin, B., Rahmani, K., Allahyari, S., Karami, K., Mahmoudi, R.,
et al. (2016). Physicochemical properties of cornelian cherry fruit (Cornus
mas L.) grown in Qazvin province. Iran. J. Biol. Todays World 5, 209–212.
doi: 10.15412/J.JBTW.01051201
Radovanovic´, B. C., Milenkovic´-Andelkovic´, A. S., Radovanovic´, A. B., and
Andelkovic´, M. Z. (2013). Antioxidant and antimicrobial activity of polyphenol
extracts from wild berry fruits grown in Southeast Serbia. Trop. J. Pharmaceut.
Res. 12, 813–819. doi: 10.4314/tjpr.v12i5.23
Radulovic´, N. S., Blagojevic´, P. D., Stojanovic´-Radic´, Z. Z., and Stojanovic´, N. M.
(2013). Antimicrobial plant metabolites: structural diversity and mechanism
of action. Curr. Med. Chem. 20, 932–952. doi: 10.2174/0929867138052
19136
Rafieian-Kopaei, M., Asgary, S., Adelnia, A., Setorki, M., Khazaei, M., Kazemi,
S., and Shamsi, F. (2011). The effects of cornelian cherry on atherosclerosis
and atherogenic factors in hypercholesterolemic rabbits. J. Med. Plants Res. 5,
2670–2676.
Rahman, I., Biswas, S. K., and Kirkham, P. A. (2006). Regulation of inflammation
and redox signaling by dietary polyphenols. Biochem. Pharmacol. 72,
1439–1452. doi: 10.1016/j.bcp.2006.07.004
Roh, C., and Jung, U. (2012). Screening of crude plant extracts with abti-obesity
activity. Int. J. Mol. Sci. 13, 1710–1719. doi: 10.3390/ijms13021710
Rop, O., Mlcek, J., Kramarova, D., and Jurikova, T. (2010). Selected cultivars of
cornelian cherry (Cornus mas L.) as a new food source for human nutrition.
Afr. J. Biotechnol. 9, 1205–1210. doi: 10.5897/AJB09.1722
Rosu, C. M., Olteanu, Z., Truta, E., Ciornea, E., Manzu, C., and Zamfirache, M. M.
(2011). Nutritional value of Rosa spp. L. and Cornus mas L. fruits, as affected by
storage conditions. Anal. Alexandru Ioan Cuza Univ. Sect. II Genet. Mol. Biol.
12, 147–155.
Rudrapaul, P., Kyriakopoulos, A. M., De, U. C., Zoumpourlis, V., and Dinda, B.
(2015). New flavonoids from the fruits of Cornus mas, Cornaceae. Phytochem.
Lett. 11, 292–295. doi: 10.1016/j.phytol.2015.01.011
Saei, H., Hatami, H., Azarmi, M., and Dehghan, G. (2016). Hepatoprotective effect
ofCornus mas fruits extract on serum biomarkers inmethotrexate induced liver
injury in male rats. Pharmacol. Online 1, 91–98.
Sak, K. (2014). Cytotoxicity of dietary flavonoids on different human cancer types.
Pharmacogn. Rev. 8, 122–146. doi: 10.4103/0973-7847.134247
Seeram, N. P., Schutzki, R., Chandra, A., and Nair, M. G. (2002). Characterization,
quantification, and bioactivities of anthocyanins in Cornus species. J. Agric.
Food Chem. 50, 2519–2523. doi: 10.1021/jf0115903
Shao, Y. (2011). Extraction of soluble dietary fiber and hemicellulose from Cornus
officinalis residue and preparation of fiber drinking water. Front. Agric. China
5, 375–381. doi: 10.1007/s11703-011-1078-2
Shishehbor, F., Azemi, M. E., Zameni, D., and Saki, A. (2016). Inhibitory effects
of hydroalcoholic extracts of barberry, sour cherry and Cornelian cherry
on α-amylase and α-glucosidase activities. Int. J. Pharm. Res. Allied Sci. 5,
423–428.
Sochor, J., Jurikova, T., Ercisli, S., Mlcek, J., Baron, M., Balla, S., et al.
(2014). Charcterization of cornelian cherry (Cornus mas L.) genotypes–genetic
resources for food production in Czech Republic. Genetika 46, 915–924.
doi: 10.2298/GENSR1403915S
Soltani, R., Gorji, A., Asgary, S., Sarrafzadegan, N., and Siavash, M. (2015).
Evaluation of the effects of Cornus mas L. fruit extract on glycemic control
and insulin level in type 2 diabetic adult patients: a randomized double-
blind placebo-controlled clinical trial. Evid. Based Complement. Alternat. Med.
2015:740954. doi: 10.1155/2015/740954
Sozanski, T., Kucharska, A. Z., Rapak, A., Szumny, D., Trocha, M., Merwid-
Lad, A., et al. (2016). Iridoid-loganic acid versus anthocyanins from the
Cornus mas fruits (cornelian cherry): common and different effects on diet-
induced atherosclerosis, PPARs expression and inflammation. Atherosclerosis
254, 151–160. doi: 10.1016/j.atherosclerosis.2016.10.001
Sozanski, T., Kucharska, A. Z., Szumny, A., Magdalan, J., Bielska, K., Merwid-
Lad, A., et al. (2014). The protective effect of the Cornus mas fruits (cornelian
cherry) on hypertriglyceridemia and atherosclerosis through PPARalpha
activation in hypercholesterolemic rabbits. Phytomedicine 21, 1774–1784.
doi: 10.1016/j.phymed.2014.09.005
Stankovic, M. S., Zia-Ul-Haq, M., Bojovic, B. M., and Topuzovic, M. D. (2014).
Total phenolics, flavonoid content and antioxidant power of leaf, flower and
fruits from cornelian cherry (Cornus mas L.). Bulg. J. Agric. Sci. 20, 358–363.
Sun, F. L., Wang, W., Cheng, H., Wang, Y., Li, L., Xue, J. L., et al.
(2014a). Morroniside improves microvascular functional integrity of
the neurovascular unit after cerebral ischemia. PLoS ONE 9:e101194.
doi: 10.1371/journal.pone.0101194
Sun, F. L., Wang, W., Zuo, W., Xue, J. L., Xu, J. D., Ai, H. X., et al. (2014b).
Promoting neurogenesis via Wnt/beta-catenin signaling pathway accounts for
the neurorestorative effects of morroniside against cerebral ischemia injury.
Eur. J. Pharmacol. 738, 214–221. doi: 10.1016/j.ejphar.2014.05.019
Sung, Y., Chang, H., Kim, S., Ym, K., Seo, J., Shin, M., et al. (2009).
Anti-inflammatory and analgesci effects of the aqueous extract of Corni
fructus in murine RAW 264.7 macrophage cells. J. Med. Food 12, 788–795.
doi: 10.1089/jmf.2008.1011
Szumny, D., Sozanski, T., Kucharska, A. Z., Dziewiszek, W., Piorecki, N.,
Magdalan, J., et al. (2015). Application of cornelian cherry iridoid-polyphenolic
fraction and loganic acid to reduce intraocular pressure. Evid. Based
Complement. Alternat. Med. 2015:939402. doi: 10.1155/2015/939402
Tarko, T., Duda-Chodak, A., Satora, P., Sroka, P., Pogon, P., and Machalica, J.
(2014). Chaenomeles japonica, Cornus mas, Morus nigra fruits characteristics
and their processing potential. J. Food Sci. Technol. 51, 3934–3941.
doi: 10.1007/s13197-013-0963-5
Tian, G., Zhang, T., Yang, F., and Ito, Y. (2000). Separation of gallic acid from
Cornus officinalis Sieb. et Zucc by high-speed counter-current chromatography.
J. Chromatogr. A 886, 309–312. doi: 10.1016/S0021-9673(00)00480-5
Frontiers in Pharmacology | www.frontiersin.org 26 August 2018 | Volume 9 | Article 894
Czerwin´ska and Melzig Comparison Cornus mas vs. C. officinalis
Tiwari, R., Latheef, S. K., Ahmed, I., Iqbal, H. M. N., Bule, M. H., Dhama,
K., et al. (2018). Herbal immunomodulators, a remedial panacea
for the designing and developing effective drugs and medicines:
Current scenario and future prospects. Curr. Drug Metab. 19, 264–301.
doi: 10.2174/1389200219666180129125436
Tural, S., and Koca, I. (2008). Physicochemical and antioxidant properties of
cornelian cherry fruits (Cornus mas L.) grown in Turkey. Sci. Hort. 116,
362–366. doi: 10.1016/j.scienta.2008.02.003
Turker, A., Yildirim, A., and Karakas, F. (2012). Antibacterial and antitumor
activities of some wild fruits grown in Turkey. Biotechnol. Biotechnol. Eq. 26,
2765–2772. doi: 10.5504/BBEQ.2011.0156
Vareed, S. K., Reddy, M. K., Schutzki, R. E., and Nair, M. G. (2006). Anthocyanins
in Cornus alternifolia, Cornus controversa, Cornus kousa and Cornus florida
fruits with health benefits. Life Sci. 78, 777–784. doi: 10.1016/j.lfs.2005.05.094
Wang, H., Wang, Z., and Guo, W. (2008). Comparative determination of ursolic
acid and oleanolic acid of Macrocarpium officinalis (Sieb. et Zucc.) Nakai by
RP-HPLC. Ind. Crops Prod. 28, 328–332. doi: 10.1016/j.indcrop.2008.03.004
Wang, W., Huang, W., Li, L., Ai, H., Sun, F., Liu, C., et al. (2008).
Morroniside prevents peroxide-induced apoptosis by induction of endogenous
glutathione in human neuroblastoma cells. Cell. Mol. Neurobiol. 28, 293–305.
doi: 10.1007/s10571-007-9168-7
Wang, W., Sun, F., An, Y., Ai, H., Zhang, L., Huang, W., et al. (2009).
Morroniside protects human neuroblastoma SH-SY5Y cells against
hydrogen peroxide-induced cytotoxicity. Eur. J. Pharmacol. 613, 19–23.
doi: 10.1016/j.ejphar.2009.04.013
Wang, W., Xu, J., Li, L., Wang, P., Ji, X., Ai, H., et al. (2010). Neuroprotective effect
of morroniside on focal cerebral ischemia in rats. Brain Res. Bull. 83, 196–201.
doi: 10.1016/j.brainresbull.2010.07.003
Wang, X., Liu, J., Jin, N. A., Xu, D., Wang, J., Han, Y., et al. (2015). Fructus Corni
extract-induced neuritogenesis in PC12 cells is associated with the suppression
of stromal interaction molecule 1 expression and inhibition of Ca(2+) influx.
Exp. Ther. Med. 9, 1773–1779. doi: 10.3892/etm.2015.2316
Wang, X., Zhang, A., Zou, D., Wang, Y., and Sun, H. (2017). “UPLC-MS
determining the active ingredients of herbal Fructus Corni in vivo,” in
Serum Pharmacochemistry of Traditional Chinese Medicine. Technologies,
Strategies and Applications, ed X. Wang (London: Academic Press; Elsevier),
269–286.
West, B. J., Deng, S., Jensen, C. J., Palu, A. K., and Berrio, L. F. (2012a). Antioxidant,
toxicity, and iridoids tests of processed Cornelian cherry fruits. Int. J. Food Sci.
Technol. 47, 1392–1397. doi: 10.1111/j.1365-2621.2012.02985.x
West, B. J., Ma, D.-L., Deng, S., Jensen, C. J., and Su, C. X. (2012b). Bioactivities
and iridoid determination of a beverage containing noni, cornelian cherries and
olive leaf extracts. Adv. J. Food Sci. Technol. 4, 91–96.
Wu, Y., Wang, X., Shen, B., Kang, L., and Fan, E. (2013). Extraction,
structure and bioactivities of the polysaccharides from Fructus corni.
Recent Pat. Food Nutr. Agric. 5, 57–61. doi: 10.2174/22127984113050
10009
Xia, B., Xu, B., Sun, Y., Xiao, L., Pan, J., Jin, H., et al. (2014). The effects of Liuwei
Dihuang on canonical Wnt/beta-catenin signaling pathway in osteoporosis. J.
Ethnopharmacol. 153, 133–141. doi: 10.1016/j.jep.2014.01.040
Xiang, Q.-Y., Brunsfeld, S., Soltis, D., and Soltis, P. (1996). Phylogenetic
relationships in Cornus based on chloroplast DNA restriction sites;
implications for biogeography and character evolution. Sys. Bot. 21, 515–534.
doi: 10.2307/2419612
Xiang, Q.-Y., Manchester, S., Thomas, D., Zhang, W., and Fan, C. (2005).
Phylogeny, biogeography, and molecular dating of cornelian cherries (Cornus,
Cornaceae): tracking tertiary plant migration. Evolution 59, 1685–1700.
doi: 10.1111/j.0014-3820.2005.tb01818.x
Xiang, Q.-Y., Moody, M., Soltis, D., Fan, C., and Soltis, P. (2002). Relationships
within Cornales and circumscription of Cornaceae–matK and rbcL sequence
data and effects of outgroups and long branches. Mol. Phylogenet. Evol. 24,
35–57. doi: 10.1016/S1055-7903(02)00267-1
Xiang, Q.-Y., Soltis, D., and Soltis, P. (1998). Phylogenetic relationships of
Cornaceae and close relatives inferred from matK and rbcL sequences. Am. J.
Bot. 85:285. doi: 10.2307/2446317
Xiang, Q.-Y., Thomas, D., Zhang, W., Manchester, S., and Murrell, Z.
(2006). Species level phylogeny of the genus Cornus (Cornaceae) based
on molecular and morphological evidence–implications for taxonomy and
Tertiary intercontinental migration. Taxon 55, 9–30. doi: 10.2307/250
65525
Xiang, Q.-Y., Thorne, J., Seo, T., Zhang, W., Thomas, D., and Ricklefs, R.
(2008). Rates of nucleotide substitution in Cornaceae (Cornales)–pattern of
variation and underlying causal factors. Mol. Phylogenet. Evol. 49, 327–342.
doi: 10.1016/j.ympev.2008.07.010
Xie, X.-Y., Wang, R., and Shi, Y.-P. (2012). Chemical constituents from
the fruits of Cornus officinalis. Biochem. Syst. Ecol. 45, 120–123.
doi: 10.1016/j.bse.2012.07.025
Xu, H., Shen, J., Liu, H., Shi, Y., Li, L., and Wie, M. (2006). Morroniside
and loganin extracted from Cornus officinalis have protective effects on rat
mesangial cell proliferation exposed to advanced glycation end products
by preventing oxidative stress. Can. J. Physiol. Pharmacol. 84, 1267–1273.
doi: 10.1139/y06-075
Yalcinkaya, E., Erbil, Y., and Bas, M. (2009). Pomological properties of some
cornelian cherry (Cornus mas L.) genotypes selected in southern Marmata
region. Acta Hort. 818, 149–154. doi: 10.17660/ActaHortic.2009.818.21
Yamabe, N., Kang, K. S., Park, C. H., Tanaka, T., and Yokozawa, T. (2009). 7-O-
galloyl-D-sedoheptulose is a novel therapeutic agent against oxidative stress
and advanced glycation endproducts in the diabetic kidney. Biol. Pharm. Bull.
32, 657–664. doi: 10.1248/bpb.32.657
Yang, C. C., Kuai, X. X., Gao, W. B., Yu, J. C., Wang, Q., Li, L., et al. (2016).
Morroniside-induced PP2A activation antagonizes tau hyperphosphorylation
in a cellular model of neurodegeneration. J. Alzheimers Dis. 51, 33–44.
doi: 10.3233/JAD-150728
Yang, L., Wang, Z., and Huang, L. (2010). Isolation and structural characterization
of a polysaccharide FCAP1 from the fruit of Cornus officinalis. Carbohydr. Res.
345, 1909–1913. doi: 10.1016/j.carres.2010.06.009
Yao, R. Q., Zhang, L., Wang, W., and Li, L. (2009). Cornel iridoid
glycoside promotes neurogenesis and angiogenesis and improves neurological
function after focal cerebral ischemia in rats. Brain Res. Bull. 79, 69–76.
doi: 10.1016/j.brainresbull.2008.12.010
Ye, X. S., He, J., Cheng, Y. C., Zhang, L., Qiao, H. Y., Pan, X. G., et al. (2017).
Cornusides A-O, bioactive iridoid glucoside dimers from the fruit of Cornus
officinalis. J. Nat. Prod. 80, 3103–3111. doi: 10.1021/acs.jnatprod.6b01127
Yilmaz, K. U., Ercisli, S., Zengin, Y., Sengul, M., and Kafkas, E. Y.
(2009). Preliminary characterisation of cornelina cherry (Cornus mas L.)
genotypes for their physico-chemical properties. Food Chem. 114, 408–412.
doi: 10.1016/j.foodchem.2008.09.055
Yin, L., Chen, Y., Qu, Z., Zhang, L., Wang, Q., Zhang, Q., et al. (2014). Involvement
of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental
autoimmune encephalomyelitis amelioration in rats. J. Neuroimmunol. 274,
28–37. doi: 10.1016/j.jneuroim.2014.06.022
Yin, X., You, Q., Jiang, Z., and Zhou, X. (2016). Optimization for ultrasonic-
microwave synergistic extraction of polysaccharides from Cornus officinalis
and characterization of polysaccharides. Int. J. Biol. Macromol. 83, 226–232.
doi: 10.1016/j.ijbiomac.2015.11.059
Yokozawa, T., Kang, K. S., Park, C. H., Noh, J. S., Yamabe, N., Shibahara, N.,
et al. (2010). Bioactive constituents of Corni fructus: the therapeutic use
of morroniside, loganin, and 7-O-galloyl-D-sedoheptulose as renoprotective
agents in type 2 diabetes. Drug Disc. Therapeut. 4, 223–234.
Yokozawa, T., Park, C. H., Noh, J. S., Tanaka, T., and Cho, E. J. (2009).
Novel action of 7-O-galloyl-D-sedoheptulose isolated from Corni Fructus
as a hypertriglyceridaemic agent. J. Pharm. Pharmacol. 61, 653–661.
doi: 10.1211/jpp/61.05.0015
Yokozawa, T., Yamabe, N., Kim, H. Y., Kang, K. S., Hur, J. M., Park, C. H., et al.
(2008). Protective effects of morroniside isolated from Corni Fructus against
renal damage in streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 31,
1422–1428. doi: 10.1248/bpb.31.1422
You, Q., Yin, X., and Zhao, Y. (2013). Enzyme assisted extraction of
polysaccharides from the fruit of Cornus officinalis. Carbohydr. Polym. 98,
607–610. doi: 10.1016/j.carbpol.2013.06.036
Youn, K., and Jun, M. (2012). Inhibitory effects of key compounds isolated
from Corni fructus on BACE1 Activity. Phytother. Res. 26, 1714–1718.
doi: 10.1002/ptr.4638
Yousefi, B., Abasi, M., Abbasi, M., and Jahanban-Esfahlan, R. (2015). Anti-
proliferative properties of Cornus mass fruit in different human cancer cells.
Asian Pac. J. Cancer Prev. 16, 5727–5731. doi: 10.7314/APJCP.2015.16.14.5727
Frontiers in Pharmacology | www.frontiersin.org 27 August 2018 | Volume 9 | Article 894
Czerwin´ska and Melzig Comparison Cornus mas vs. C. officinalis
Yu, H.-H., Hur, J.-M., Seo, S.-J., Moon, H.-D., Kim, H.-J., Park, R.-K.,
et al. (2009). Protective effect of ursolic acid from Cornus officinalis
on the hydrogen peroxide-induced damage of HEI-OC1 auditory
cells. Am. J. Chin. Med. 37, 735–746. doi: 10.1142/S0192415X0
900720X
Zhang, Q.-A., Fan, X.-H., Zhao, W.-Q., Wang, X.-Y., and Liu, H.-Z. (2013).
Evolution of some physicochemical properties in Cornus officinalis wine
during fermentation and storage. Eur. Food Res. Technol. 237, 711–719.
doi: 10.1007/s00217-013-2045-3
Zhang, Q. C., Zhao, Y., and Bian, H. M. (2013). Antiplatelet activity of a novel
formula composed of malic acid, succinic acid and citric acid from Cornus
officinalis fruit. Phytother. Res. 27, 1894–1896. doi: 10.1002/ptr.4934
Zhang, W., Hong, D., Zhou, Y., Zhang, Y., Shen, Q., Li, J. Y., et al. (2006).
Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B,
enhancing insulin receptor phosphorylation and stimulating glucose uptake.
Biochim. Biophys. Acta 1760, 1505–1512. doi: 10.1016/j.bbagen.2006.0
5.009
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Czerwin´ska and Melzig. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication
in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Pharmacology | www.frontiersin.org 28 August 2018 | Volume 9 | Article 894
